{ "source_url": "https://clinicaltrials.gov", "register_url": "https://priyalifescience.com/clinical-trials-china", "fetched_at": "2026-11-07T03:17:25+00:00", "registry_total_matching_open_statuses": 19187, "count": 19187, "page": 1, "per": 500, "results": [ { "nct_id": "NCT06974968", "title": "Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.", "conditions": [ "Spinal Cord Injury", "Safety", "Efficacy", "Clinical Trial" ], "sites": [ "Guangzhou" ], "enrollment": 60, "start_date": "2028-05-25", "registry_url": "https://clinicaltrials.gov/study/NCT06974968" }, { "nct_id": "NCT06990178", "title": "Adaptive Neoadjuvant Therapy for Esophageal Cancer", "status": "ENROLLING_BY_INVITATION", "phase": "Not applicable", "lead_sponsor": "Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center", "conditions": [ "Esophageal Carcinoma", "Neoadjuvant Therapy" ], "sites": [ "Shenzhen" ], "enrollment": 43, "start_date": "2028-03-01", "registry_url": "https://clinicaltrials.gov/study/NCT06990178" }, { "nct_id": "NCT07044700", "title": "Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Boehringer Ingelheim", "conditions": [ "Heart Failure of Reduced Ejection Fraction (HFrEF)" ], "sites": [ "Beijing" ], "enrollment": 5000, "start_date": "2028-01-31", "registry_url": "https://clinicaltrials.gov/study/NCT07044700" }, { "nct_id": "NCT07318909", "title": "To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Gritgen Therapeutics Co., Ltd.", "conditions": [ "Phenylketonuria (PKU)" ], "sites": [ "Hefei" ], "enrollment": 9, "start_date": "2027-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT07318909" }, { "nct_id": "NCT07382375", "title": "AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Nanjing Medical University", "conditions": [ "Aortic Aneurysm and Dissection" ], "sites": [ "Beijing", "Changzhou", "Chengdu", "Fuzhou", "Guangzhou", "Nanchang", "Nanjing", "Shanghai" ], "enrollment": 300, "start_date": "2027-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT07382375" }, { "nct_id": "NCT05745740", "title": "A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "RemeGen Co., Ltd.", "conditions": [ "Non-small Cell Lung Cancer" ], "sites": [ "Shanghai" ], "enrollment": 26, "start_date": "2027-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT05745740" }, { "nct_id": "NCT07695740", "title": "Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Excyte Biopharma Ltd", "conditions": [ "Relapsed or Refractory Multiple Myeloma (RRMM)" ], "sites": [ "Beijing" ], "enrollment": 64, "start_date": "2027-12", "registry_url": "https://clinicaltrials.gov/study/NCT07695740" }, { "nct_id": "NCT07789483", "title": "An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Alexion Pharmaceuticals, Inc.", "conditions": [ "Transthyretin Amyloid Cardiomyopathy (ATTR-CM)" ], "sites": [ "Beijing", "Chongqing", "Guangzhou", "Guiyang", "Harbin", "Wuhan", "Changsha", "Nanjing" ], "enrollment": 1180, "start_date": "2027-11-23", "registry_url": "https://clinicaltrials.gov/study/NCT07789483" }, { "nct_id": "NCT07707882", "title": "Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Tenosynovial Giant Cell Tumor, Diffuse" ], "sites": [ "Hangzhou" ], "enrollment": 84, "start_date": "2027-10-01", "registry_url": "https://clinicaltrials.gov/study/NCT07707882" }, { "nct_id": "NCT07691645", "title": "Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Xiang-Qian", "conditions": [ "HCC - Hepatocellular Carcinoma", "Chinese Herbal Medicine", "ICG (Indocyanine Green)", "Overall Survival (All-cause Mortality)" ], "sites": [ "Hangzhou" ], "enrollment": 120, "start_date": "2027-09-01", "registry_url": "https://clinicaltrials.gov/study/NCT07691645" }, { "nct_id": "NCT07735143", "title": "iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Shanghai Mental Health Center", "conditions": [ "Major Depressive Disorder (MDD)" ], "sites": [ "Shanghai" ], "enrollment": 150, "start_date": "2027-09-01", "registry_url": "https://clinicaltrials.gov/study/NCT07735143" }, { "nct_id": "NCT07170293", "title": "Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tianjin Medical University Second Hospital", "conditions": [ "Solid Cancers" ], "sites": [ "Tianjin" ], "enrollment": 15, "start_date": "2027-08-31", "registry_url": "https://clinicaltrials.gov/study/NCT07170293" }, { "nct_id": "NCT07751003", "title": "Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sir Run Run Shaw Hospital", "conditions": [ "COPD (Chronic Obstructive Pulmonary Disease)", "Acute Exacerbation of COPD", "Hypercapnia" ], "sites": [ "Zhengzhou", "Changsha", "Hangzhou", "Wenling" ], "enrollment": 236, "start_date": "2027-08-01", "registry_url": "https://clinicaltrials.gov/study/NCT07751003" }, { "nct_id": "NCT07885982", "title": "Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Anhui Provincial Hospital", "conditions": [ "Aplastic Anaemia" ], "sites": [ "Hefei" ], "enrollment": 59, "start_date": "2027-08-01", "registry_url": "https://clinicaltrials.gov/study/NCT07885982" }, { "nct_id": "NCT07389499", "title": "A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Grit Biotechnology", "conditions": [ "IgA Nephropathy (IgAN)", "Membranous Nephropathy", "ANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)", "Refractory Podocytopathy" ], "sites": [ "Shanghai" ], "enrollment": 30, "start_date": "2027-08", "registry_url": "https://clinicaltrials.gov/study/NCT07389499" }, { "nct_id": "NCT03645486", "title": "Lentiviral Gene Therapy for CGD", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Chronic Granulomatous Disease" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-07-01", "registry_url": "https://clinicaltrials.gov/study/NCT03645486" }, { "nct_id": "NCT04980703", "title": "Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Institute of Acupuncture, Moxibustion and Meridian", "conditions": [ "Sleep Initiation and Maintenance Disorders" ], "sites": [ "Shanghai" ], "enrollment": 102, "start_date": "2027-07-01", "registry_url": "https://clinicaltrials.gov/study/NCT04980703" }, { "nct_id": "NCT04433221", "title": "Combination Immunotherapy Targeting Sarcomas", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Sarcoma", "Osteoid Sarcoma", "Ewing Sarcoma" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2027-07-01", "registry_url": "https://clinicaltrials.gov/study/NCT04433221" }, { "nct_id": "NCT07781748", "title": "Improving Quality of Informal Care for People With Schizophrenia", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Chinese University of Hong Kong", "conditions": [ "Schizophrenia" ], "sites": [ "Chengdu" ], "enrollment": 228, "start_date": "2027-07-01", "registry_url": "https://clinicaltrials.gov/study/NCT07781748" }, { "nct_id": "NCT04016129", "title": "CAR-T Immunotherapy Targeting CD19- ALL", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "B-cell Leukemia" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2027-07-01", "registry_url": "https://clinicaltrials.gov/study/NCT04016129" }, { "nct_id": "NCT06435910", "title": "Engineered Dendritic Cell Vaccines for Multiple Myeloma", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Multiple Myeloma or Plasmacytoma" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT06435910" }, { "nct_id": "NCT07495956", "title": "cfMSC Therapy for Diabetes", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Type II Diabetes Mellitus" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT07495956" }, { "nct_id": "NCT06435897", "title": "Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Autoimmune Diseases" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT06435897" }, { "nct_id": "NCT05995041", "title": "Universal CAR-T Cells Targeting AML", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Acute Myeloid Leukemia" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT05995041" }, { "nct_id": "NCT06006741", "title": "Universal CAR-T Cells Targeting Multiple Myeloma", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Multiple Myeloma in Remission" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT06006741" }, { "nct_id": "NCT05995028", "title": "Universal 4SCAR7U Targeting CD7-positive Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "T-cell Acute Lymphoblastic Leukemia", "T-cell Acute Lymphoblastic Lymphoma", "Acute Myeloid Leukemia", "NK Cell Lymphoma" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT05995028" }, { "nct_id": "NCT03645460", "title": "Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT03645460" }, { "nct_id": "NCT03217617", "title": "SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "SCID, X-Linked" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT03217617" }, { "nct_id": "NCT07501156", "title": "H3K27M-specific Immune Effector Cells Targeting DMG/DIPG", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT07501156" }, { "nct_id": "NCT06739226", "title": "Combination Immunotherapy Targeting Melanoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Melanoma" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT06739226" }, { "nct_id": "NCT07477600", "title": "cfMSC Stem Cell Therapy Targeting COPD", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Chronic Obstructive Pulmonary Disease (COPD)" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-30", "registry_url": "https://clinicaltrials.gov/study/NCT07477600" }, { "nct_id": "NCT03217032", "title": "Lentiviral FVIII Gene Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Hemophilia A" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT03217032" }, { "nct_id": "NCT04429438", "title": "Multi-CAR-T Cells Targeting B Cell Lymphomas", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "B Cell Lymphoma (BCL)" ], "sites": [ "Shenzhen" ], "enrollment": 11, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT04429438" }, { "nct_id": "NCT07180927", "title": "DLL3 CAR-T Therapy Targeting Brain Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Glioblastoma of Cerebellum" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT07180927" }, { "nct_id": "NCT03356782", "title": "Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Sarcoma", "Osteoid Sarcoma", "Ewing Sarcoma" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT03356782" }, { "nct_id": "NCT05436496", "title": "CD19/70 Bi-specific CAR-T Cell Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "B Cell Malignancies" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT05436496" }, { "nct_id": "NCT05459870", "title": "CAR-T Cells Targeting Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Autoimmune Diseases" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT05459870" }, { "nct_id": "NCT03356808", "title": "Antigen-specific T Cells Against Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Lung Cancer" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT03356808" }, { "nct_id": "NCT05432882", "title": "CD19/22 Bi-specific CAR-T Cell Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "B Cell Malignancies" ], "sites": [ "Shenzhen" ], "enrollment": 60, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT05432882" }, { "nct_id": "NCT04432649", "title": "Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Solid Tumor" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT04432649" }, { "nct_id": "NCT03727555", "title": "IT and IV Lentiviral Gene Therapy for X-ALD", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "X-linked Adrenoleukodystrophy" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT03727555" }, { "nct_id": "NCT03614650", "title": "Immunotherapy Treating GI Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Cancer" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT03614650" }, { "nct_id": "NCT03961243", "title": "Lentiviral FIX Gene Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Hemophilia B" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT03961243" }, { "nct_id": "NCT04430595", "title": "Multi-4SCAR-T Therapy Targeting Breast Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Breast Cancer" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT04430595" }, { "nct_id": "NCT07046338", "title": "Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Metachromatic Leukodystrophy (MLD)" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-06-01", "registry_url": "https://clinicaltrials.gov/study/NCT07046338" }, { "nct_id": "NCT07872189", "title": "Dyadic Cognitive Intervention for Older Adults With Cognitive Impairment and Their Spouses", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Gansu University of Chinese Medicine", "conditions": [ "Cognitive Impairment" ], "sites": [ "Lanzhou" ], "enrollment": 136, "start_date": "2027-06", "registry_url": "https://clinicaltrials.gov/study/NCT07872189" }, { "nct_id": "NCT07309380", "title": "Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Shanghai HEP Pharmaceutical Co., Ltd.", "conditions": [ "Hepatitis D, Chronic" ], "sites": [ "Changchun" ], "enrollment": 150, "start_date": "2027-06", "registry_url": "https://clinicaltrials.gov/study/NCT07309380" }, { "nct_id": "NCT03725670", "title": "Direct Lentiviral Injection Gene Therapy for MLD", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Metachromatic Leukodystrophy (MLD)" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2027-05-31", "registry_url": "https://clinicaltrials.gov/study/NCT03725670" }, { "nct_id": "NCT07676006", "title": "A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Grit Biotechnology", "conditions": [ "Relapsed/Refractory Acute Myeloid Leukemia (AML)" ], "sites": [ "Shenzhen" ], "enrollment": 36, "start_date": "2027-05", "registry_url": "https://clinicaltrials.gov/study/NCT07676006" }, { "nct_id": "NCT07897955", "title": "Tenecteplase in Acute Ischemic Stroke Under Different Transfer Models", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Fujian Medical University Union Hospital", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Fuzhou", "Zhangzhou", "Lanzhou", "Mudanjiang", "Liaocheng", "Shanghai" ], "enrollment": 2000, "start_date": "2027-04-01", "registry_url": "https://clinicaltrials.gov/study/NCT07897955" }, { "nct_id": "NCT07912970", "title": "Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion Stroke Within 4.5-24 Hours", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Fujian Medical University Union Hospital", "conditions": [ "Acute Ischemic Stroke", "Large Vessel Occlusion" ], "sites": [ "Fuzhou" ], "enrollment": 1266, "start_date": "2027-04-01", "registry_url": "https://clinicaltrials.gov/study/NCT07912970" }, { "nct_id": "NCT07698223", "title": "Naoxintong Capsule for Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialAcronymNXT-DKD", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Chen Xiangmei", "conditions": [ "Diabetic Nephropathy" ], "sites": [ "Beijing", "Chongqing", "Dalian", "Shanghai", "Hangzhou" ], "enrollment": 410, "start_date": "2027-03-01", "registry_url": "https://clinicaltrials.gov/study/NCT07698223" }, { "nct_id": "NCT07767604", "title": "Effectiveness of the MindBridge Mobile Health Module for Young Adults at Risk of Suicide", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Jiangsu Medical College", "conditions": [ "Suicidal Ideation" ], "sites": [ "Yancheng" ], "enrollment": 84, "start_date": "2027-03", "registry_url": "https://clinicaltrials.gov/study/NCT07767604" }, { "nct_id": "NCT07841093", "title": "A Study of JMKX003142 Tablet to Treat Renal Edema", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jemincare", "conditions": [ "Renal Edema", "Nephrogenic Edema" ], "sites": [ "Shanghai" ], "enrollment": 240, "start_date": "2027-02-28", "registry_url": "https://clinicaltrials.gov/study/NCT07841093" }, { "nct_id": "NCT07891416", "title": "Phase II Clinical Study on Preliminary Efficacy and Safety of ETD-001 Gel for Hypertrophic Scars", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Etern Therapeutics Wuxi Limited", "conditions": [ "Hypertrophic Scars" ], "sites": [ "Shanghai" ], "enrollment": 90, "start_date": "2027-02-28", "registry_url": "https://clinicaltrials.gov/study/NCT07891416" }, { "nct_id": "NCT07847515", "title": "Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": [ "Obesity / Overweight" ], "sites": [ "Nanjing" ], "enrollment": 80, "start_date": "2027-02-01", "registry_url": "https://clinicaltrials.gov/study/NCT07847515" }, { "nct_id": "NCT07470840", "title": "SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fujian Cancer Hospital", "conditions": [ "Locally Advanced or Metastatic Renal Cell Carcinoma" ], "sites": [ "Fuzhou" ], "enrollment": 27, "start_date": "2027-02-01", "registry_url": "https://clinicaltrials.gov/study/NCT07470840" }, { "nct_id": "NCT07697079", "title": "Combination of CT and Ultrasound Radiomics Combined With Liquid Biopsy to Predict Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Gastric Cancer", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Liu Yang", "conditions": [ "Gastric Cancer" ], "sites": [ "Jinan" ], "enrollment": 300, "start_date": "2027-02-01", "registry_url": "https://clinicaltrials.gov/study/NCT07697079" }, { "nct_id": "NCT06902012", "title": "Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Zhujiang Hospital", "conditions": [ "Relapsed/Refractory Diffuse Large B-cell Lymphoma" ], "sites": [ "Guangzhou" ], "enrollment": 15, "start_date": "2027-02", "registry_url": "https://clinicaltrials.gov/study/NCT06902012" }, { "nct_id": "NCT07914894", "title": "A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": [ "Paroxysmal Nocturnal Hemoglobinuria" ], "sites": [ "Hangzhou", "Tianjin" ], "enrollment": 20, "start_date": "2027-01-26", "registry_url": "https://clinicaltrials.gov/study/NCT07914894" }, { "nct_id": "NCT07916636", "title": "Detection Technology of Peripheral Blood ctDNA Based on CRISPR/Cas and Gold Nanoparticles", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "The First Affiliated Hospital of Zhengzhou University", "conditions": [ "Cancer", "Circulating Tumor DNA Detection" ], "sites": [ "Zhengzhou" ], "enrollment": 100, "start_date": "2027-01-21", "registry_url": "https://clinicaltrials.gov/study/NCT07916636" }, { "nct_id": "NCT07915219", "title": "A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY\u00ae-ON)", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Boehringer Ingelheim", "conditions": [ "Bronchiectasis" ], "sites": [ "Beijing", "Changchun", "Changsha", "Chengdu", "Guangzhou", "Guiyang", "Hangzhou", "Hefei" ], "enrollment": 1500, "start_date": "2027-01-11", "registry_url": "https://clinicaltrials.gov/study/NCT07915219" }, { "nct_id": "NCT07922330", "title": "A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "AstraZeneca", "conditions": [ "Obesity", "Overweight", "Type 2 Diabetes Mellitus" ], "sites": [ "Beijing", "Bozhou", "Cangzhou", "Changzhou", "Chongqing", "Daqing", "Ganzhou", "Guangzhou" ], "enrollment": 330, "start_date": "2027-01-04", "registry_url": "https://clinicaltrials.gov/study/NCT07922330" }, { "nct_id": "NCT07917429", "title": "Real-World Study: Panitumumab N01 vs Cetuximab Plus FOLFOX in First-Line RAS Wild-Type mCRC", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Fujian Medical University Union Hospital", "conditions": [ "Colorectal Cancer Metastatic" ], "sites": [ "Fuzhou" ], "enrollment": 610, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07917429" }, { "nct_id": "NCT07277218", "title": "Drug-coated Balloons Versus Drug-eluting Stents for the Treatment of Femoropopliteal In-Stent Restenosis", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Chunshui He", "conditions": [ "Femoropopliteal In-Stent Restenosis (ISR)" ], "sites": [ "Beijing", "Xiamen", "Hangzhou", "Wuhan", "Suzhou", "Qingdao", "Shanghai", "Chengdu" ], "enrollment": 600, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07277218" }, { "nct_id": "NCT07466511", "title": "Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Second Affiliated Hospital of Wenzhou Medical University", "conditions": [ "Idiopathic Scoliosis" ], "sites": [ "Wenzhou" ], "enrollment": 100, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07466511" }, { "nct_id": "NCT07890064", "title": "Canagliflozin Plus Progestin for Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Wang Yingmei", "conditions": [ "Endometrioid Endometrial Cancer", "Atypical Endometrial Hyperplasia" ], "sites": [ "Tianjin" ], "enrollment": 102, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07890064" }, { "nct_id": "NCT07056478", "title": "RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Prince of Wales Hospital, Shatin, Hong Kong", "conditions": [ "Sarcopenia in Elderly" ], "sites": [ "Hong Kong" ], "enrollment": 130, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07056478" }, { "nct_id": "NCT07912853", "title": "Integration of Imaging, Molecular, Pathological, and Clinical Outcome Data in Hepatocellular Carcinoma.", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "West China Hospital", "conditions": [ "Resectable Hepatocellular Carcinoma (HCC)" ], "sites": [ "Chengdu" ], "enrollment": 380, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07912853" }, { "nct_id": "NCT07686796", "title": "Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Guangdong Provincial People's Hospital", "conditions": [ "Local Advanced Rectal Cancer", "PD-1 Inhibitor", "PCSK9 Inhibitor", "RCT" ], "sites": [ "Guangzhou" ], "enrollment": 148, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07686796" }, { "nct_id": "NCT07197021", "title": "TEER In dynaMic sEvere Functional Mitral Regurgitation (TIMER)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Mitral Regurgitation Functional" ], "sites": [ "Guangzhou" ], "enrollment": 540, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07197021" }, { "nct_id": "NCT07758400", "title": "A Study on the Efficacy and Safety of Microneedling for Male Androgenetic Alopecia", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Cheng Zhou", "conditions": [ "Androgenetic Alopecia" ], "sites": [ "Beijing" ], "enrollment": 190, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07758400" }, { "nct_id": "NCT07700524", "title": "Intraoperative Ultrasound Assessment of Coronary Artery and Bypass Graft Blood Flow During CABG", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": [ "Coronary Artery Disease" ], "sites": [ "Nanjing" ], "enrollment": 190, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07700524" }, { "nct_id": "NCT07844018", "title": "ADC Based Therapy Accroding to HER2 Heterogeneous", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Breast Cancer (Early Breast Cancer)" ], "sites": [ "Beijing" ], "enrollment": 88, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07844018" }, { "nct_id": "NCT07913516", "title": "Feasibility Study of Huangqi Yangyuan Formula for Capecitabine-Induced Adverse Reactions in Advanced Colorectal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Huanfang Fan", "conditions": [ "Advanced Colorectal Cancer", "Capecitabine-Related Adverse Reaction" ], "sites": [ "Shijiazhuang" ], "enrollment": 35, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07913516" }, { "nct_id": "NCT07715760", "title": "Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Xiyuan Hospital of China Academy of Chinese Medical Sciences", "conditions": [ "Functional Dyspepsia", "Irritable Bowel Syndrome With Diarrhea" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07715760" }, { "nct_id": "NCT07419880", "title": "Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fudan University", "conditions": [ "Triple -Negative Breast Cancer" ], "sites": [ "Shanghai" ], "enrollment": 46, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07419880" }, { "nct_id": "NCT07808021", "title": "Comparative Effects of Acceptance and Commitment Therapy, Cognitive Behavioral Therapy, and Treatment-as-Usual on Depression Among People With Marital Crisis", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Universiti Sains Malaysia", "conditions": [ "Depression - Major Depressive Disorder", "Anxiety", "Marital Conflict" ], "sites": [ "Yunfu" ], "enrollment": 120, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07808021" }, { "nct_id": "NCT07444463", "title": "Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Central South University", "conditions": [ "Schizophrenia", "Bipolar Disorder", "Major Depressive Disorder (MDD)" ], "sites": [ "Changsha" ], "enrollment": 400, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07444463" }, { "nct_id": "NCT07615296", "title": "Target-Oriented Strategy of Ultra-Low LDL-C (<1.0 vs. 1.0-1.39 mmol/L) in Extreme-High-Risk ASCVD Patients: Clinical Benefit, Safety and Cost-Effectiveness Assessment", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Anzhen Hospital", "conditions": [ "Atherosclerotic Cardiovascular Disease (ASCVD)" ], "sites": [ "Beijing" ], "enrollment": 6000, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07615296" }, { "nct_id": "NCT07910357", "title": "High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in Children High-altitude Pulmonary Edema", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Ye Fan", "conditions": [ "High-altitude Pulmonary Edema" ], "sites": [ "Lhasa" ], "enrollment": 116, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07910357" }, { "nct_id": "NCT07878026", "title": "Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Jinling Hospital, China", "conditions": [ "Pouchitis", "UC - Ulcerative Colitis" ], "sites": [ "Nanjing" ], "enrollment": 12, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07878026" }, { "nct_id": "NCT05595239", "title": "Blood Purification in Septic Children", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Children's Hospital of Fudan University", "conditions": [ "Sepsis", "Blood Purification" ], "sites": [ "Shanghai" ], "enrollment": 120, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT05595239" }, { "nct_id": "NCT07368504", "title": "AI for Newborn Metabolic Screening", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": [ "Inherited Metabolic Disorders" ], "sites": [ "Hangzhou" ], "enrollment": 200000, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07368504" }, { "nct_id": "NCT07600216", "title": "A Multicenter, Randomized Controlled Superiority Trial Comparing Robotic-Assisted Versus Expert Cognitive Fusion Prostate Biopsy in Obese Men", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai East Hospital", "conditions": [ "Prostate Biopsy" ], "sites": [ "Shanghai" ], "enrollment": 570, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07600216" }, { "nct_id": "NCT07853053", "title": "DV Plus Toripalimab With Cetirizine and Mecobalamin Pretreatment in Patients With Locally Advanced Unresectable or Metastatic Bladder Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": [ "Bladder Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 20, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07853053" }, { "nct_id": "NCT07907861", "title": "Sacituzumab Tirumotecan Plus Toripalimab for Advanced Penile Cancer After Platinum Chemotherapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Anhui Provincial Hospital", "conditions": [ "Penile Squamous Cell Carcinoma (PSCC)", "Advanced Penile Cancer", "Metastatic Penile Cancer", "Locally Advanced Penile Cancer" ], "sites": [ "Hefei" ], "enrollment": 31, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07907861" }, { "nct_id": "NCT07898267", "title": "Gut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Second Affiliated Hospital of Nanchang University", "conditions": [ "Obesity & Overweight" ], "sites": [ "Nanchang" ], "enrollment": 150, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07898267" }, { "nct_id": "NCT07879365", "title": "Effect of Weight Management on AMPK Activation in the Adjunctive Treatment of Endometrial Cancer", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Endometrial Cancer" ], "sites": [ "Beijing" ], "enrollment": 160, "start_date": "2027-01-01", "registry_url": "https://clinicaltrials.gov/study/NCT07879365" }, { "nct_id": "NCT07885930", "title": "A Prospective Multicenter Registry Study of Sedation and Analgesia in Critically Ill Patients", "status": "ENROLLING_BY_INVITATION", "phase": "Observational", "lead_sponsor": "Beijing Chao Yang Hospital", "conditions": [ "Sedation", "Analgesia Assessment", "ICU" ], "sites": [ "Beijing" ], "enrollment": 2000, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07885930" }, { "nct_id": "NCT07915258", "title": "Becotatug Vedotin Plus Pucotenlimab in Locally Advanced Head and Neck Squamous Cell Carcinoma With Suboptimal Response to Induction Immunochemotherapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Squamous Cell Carcinoma of Head and Neck (SCCHN)" ], "sites": [ "Guangzhou", "Shenzhen" ], "enrollment": 22, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07915258" }, { "nct_id": "NCT07720687", "title": "Template-Guided Burr-Hole Drainage With Middle Meningeal Artery Coagulation for Chronic Subdural Hematoma", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Second Hospital of Anhui Medical University", "conditions": [ "Chronic Subdural Hematoma" ], "sites": [ "Hefei" ], "enrollment": 440, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07720687" }, { "nct_id": "NCT07138846", "title": "A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Lepu Biopharma Co., Ltd.", "conditions": [ "Advanced Pancreatic Cancer" ], "sites": [ "Shanghai" ], "enrollment": 231, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07138846" }, { "nct_id": "NCT07657416", "title": "NK521 in the Treatment of Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Base Therapeutics (Shanghai) Co., Ltd.", "conditions": [ "Hepatocellular Carcinoma (HCC)", "Ovarian Cancer", "Malignant Ascites" ], "sites": [ "Hefei" ], "enrollment": 18, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07657416" }, { "nct_id": "NCT07731620", "title": "Frontal vs Parietal Eminence Drainage for Chronic Subdural Hematoma", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Second Hospital of Anhui Medical University", "conditions": [ "Chronic Subdural Hematoma" ], "sites": [ "Hefei", "Huai'an", "Yangzhou" ], "enrollment": 440, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07731620" }, { "nct_id": "NCT07747402", "title": "Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 Diabetes", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Xi'an International Medical Center Hospital", "conditions": [ "Type 2 Diabetes" ], "sites": [ "Xi'an" ], "enrollment": 462, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07747402" }, { "nct_id": "NCT07871240", "title": "Yijinjing Exercise for Musculoskeletal Health in Adults With Sarcopenia", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Hospital of Traditional Chinese Medicine", "conditions": [ "Sarcopenia" ], "sites": [ "Beijing" ], "enrollment": 240, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07871240" }, { "nct_id": "NCT07901504", "title": "Remimazolam vs Propofol for Motor and Somatosensory Evoked Potentials in Spinal Tumor Surgery", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Beijing Tsinghua Chang Gung Hospital", "conditions": [ "Spinal Cord Neoplasms", "Spinal Neoplasms" ], "sites": [ "Beijing" ], "enrollment": 190, "start_date": "2027-01", "registry_url": "https://clinicaltrials.gov/study/NCT07901504" }, { "nct_id": "NCT04429451", "title": "PSMA-specific CAR-T Cell Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "PSMA Positive Tumors or Tumor Tissues" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT04429451" }, { "nct_id": "NCT03351829", "title": "Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Beta-Thalassemia" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT03351829" }, { "nct_id": "NCT05438368", "title": "GD2/CD70 Bi-specific CAR-T Cell Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Cancer Disease" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT05438368" }, { "nct_id": "NCT07341672", "title": "A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": [ "Healthy Adult Subject" ], "sites": [ "Jinan" ], "enrollment": 80, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT07341672" }, { "nct_id": "NCT07523282", "title": "Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen MagicRNA Biotechnology Co., Ltd", "conditions": [ "Autoimmune Disease", "Systemic Lupus Erythematosus", "Systemic Sclerosis (SSc)" ], "sites": [ "Hefei" ], "enrollment": 12, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT07523282" }, { "nct_id": "NCT04637503", "title": "4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Neuroblastoma" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT04637503" }, { "nct_id": "NCT06429150", "title": "Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Multiple Myeloma", "Plasmacytoma" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT06429150" }, { "nct_id": "NCT05995015", "title": "4SCAR19U T Cells Targeting B Cell Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "B Cell Malignancies" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT05995015" }, { "nct_id": "NCT05437315", "title": "GD2/PSMA Bi-specific CAR-T Cell Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Solid Tumor" ], "sites": [ "Shenzhen" ], "enrollment": 60, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT05437315" }, { "nct_id": "NCT07345780", "title": "Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Donghua Zhang", "conditions": [ "CD7-Positive Hematological Malignancies" ], "sites": [ "Wuhan" ], "enrollment": 28, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT07345780" }, { "nct_id": "NCT04033302", "title": "Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "T-cell Acute Lymphoblastic Leukemia", "T-cell Acute Lymphoblastic Lymphoma", "Acute Myeloid Leukemia", "NK Cell Lymphoma" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT04033302" }, { "nct_id": "NCT03914768", "title": "Immune Modulatory DC Vaccine Against Brain Tumor", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Diffuse Intrinsic Pontine Glioma or Glioblastoma" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT03914768" }, { "nct_id": "NCT02992210", "title": "Study on GD2 Positive Solid Tumors by 4SCAR-GD2", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Solid Tumor" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT02992210" }, { "nct_id": "NCT05560373", "title": "The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Wanbangde Pharmaceutical Group Co., LTD", "conditions": [ "Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage" ], "sites": [ "Hangzhou" ], "enrollment": 60, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT05560373" }, { "nct_id": "NCT03222674", "title": "Multi-CAR T Cell Therapy for Acute Myeloid Leukemia", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Acute Myeloid Leukemia" ], "sites": [ "Shenzhen" ], "enrollment": 10, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT03222674" }, { "nct_id": "NCT03123458", "title": "Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Immune Related Disorder", "Tissue Damage" ], "sites": [ "Shenzhen" ], "enrollment": 100, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT03123458" }, { "nct_id": "NCT03271632", "title": "Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shenzhen Geno-Immune Medical Institute", "conditions": [ "Multiple Myeloma" ], "sites": [ "Shenzhen" ], "enrollment": 20, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT03271632" }, { "nct_id": "NCT07556120", "title": "Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shenzhen MagicRNA Biotechnology Co., Ltd", "conditions": [ "Generalized Myasthenia Gravis" ], "sites": [ "Hefei" ], "enrollment": 6, "start_date": "2026-12-31", "registry_url": "https://clinicaltrials.gov/study/NCT07556120" }, { "nct_id": "NCT07331220", "title": "Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection Fraction", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": [ "Heart Failure With Preserved Ejection Fraction" ], "sites": [ "Nanjing" ], "enrollment": 310, "start_date": "2026-12-30", "registry_url": "https://clinicaltrials.gov/study/NCT07331220" }, { "nct_id": "NCT07349979", "title": "PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": [ "Heart Failure With Reduced Ejection Fraction", "Coronary Artery Disease", "Stable GDMT" ], "sites": [ "Nanjing" ], "enrollment": 1154, "start_date": "2026-12-30", "registry_url": "https://clinicaltrials.gov/study/NCT07349979" }, { "nct_id": "NCT07919951", "title": "RAPID for Unresectable Colorectal Liver Metastases", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": [ "Colorectal Liver Metastases (CRCLM)", "Colorectal Neoplasms" ], "sites": [ "Guangzhou" ], "enrollment": 10, "start_date": "2026-12-30", "registry_url": "https://clinicaltrials.gov/study/NCT07919951" }, { "nct_id": "NCT07574463", "title": "Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Children's Hospital of Zhejiang University School of Medicine", "conditions": [ "Congenital Heart Disease (CHD)", "Congenital Heart Disease in Children" ], "sites": [ "Hangzhou" ], "enrollment": 130, "start_date": "2026-12-30", "registry_url": "https://clinicaltrials.gov/study/NCT07574463" }, { "nct_id": "NCT06136507", "title": "Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Hangzhou Gensciences Biopharmaceutical Co., Ltd.", "conditions": [ "Severe Hemophilia A" ], "sites": [ "Chongqing", "Guangzhou", "Guizhou", "Hangzhou", "Hefei", "Nanjing", "Qingdao", "Shenzhen" ], "enrollment": 76, "start_date": "2026-12-25", "registry_url": "https://clinicaltrials.gov/study/NCT06136507" }, { "nct_id": "NCT07314203", "title": "Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Fujian Medical University", "conditions": [ "Gastric Cancer", "Surgery" ], "sites": [ "Fuzhou" ], "enrollment": 118, "start_date": "2026-12-25", "registry_url": "https://clinicaltrials.gov/study/NCT07314203" }, { "nct_id": "NCT07496762", "title": "Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Kaili Chen", "conditions": [ "Stroke Sequelae", "Deglutition Disorders", "Acupuncture Therapy", "Electroacupuncture" ], "sites": [ "Hangzhou" ], "enrollment": 102, "start_date": "2026-12-21", "registry_url": "https://clinicaltrials.gov/study/NCT07496762" }, { "nct_id": "NCT07917897", "title": "Individualized Inspired Oxygen Fraction Titration During Lung Surgery (iOXY-LUNG)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Pulmonary Hospital, Shanghai, China", "conditions": [ "Postoperative Complications" ], "sites": [ "Hefei", "Nanjing", "Shanghai" ], "enrollment": 628, "start_date": "2026-12-20", "registry_url": "https://clinicaltrials.gov/study/NCT07917897" }, { "nct_id": "NCT07842185", "title": "A Multicenter, Open-label, Randomized, Non-inferiority Clinical Trial With Blinded Endpoint Assessment of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic Stroke", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Xinqiao Hospital of Chongqing", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Fuyang", "Longyan", "Xiangtan", "Ganzhou", "Jingdezhen", "Jiujiang", "Dalian", "Mianyang" ], "enrollment": 1192, "start_date": "2026-12-19", "registry_url": "https://clinicaltrials.gov/study/NCT07842185" }, { "nct_id": "NCT07598825", "title": "A Trial of Inebilizumab in Participants With Autoimmune Hepatitis", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Amgen", "conditions": [ "Autoimmune Hepatitis", "AIH" ], "sites": [ "Hefei", "Beijing", "Chongqing", "Fuzhou", "Zhengzhou", "Wuhan", "Nanjing", "Suzhou" ], "enrollment": 180, "start_date": "2026-12-18", "registry_url": "https://clinicaltrials.gov/study/NCT07598825" }, { "nct_id": "NCT07441408", "title": "Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Bristol-Myers Squibb", "conditions": [ "Pulmonary Fibrosis" ], "sites": [ "Hefei", "Beijing", "Shenzhen", "Guangzhou", "Shenzhen Shi", "Zhengzhou", "Shijiazhuang", "Yichang Shi" ], "enrollment": 2380, "start_date": "2026-12-16", "registry_url": "https://clinicaltrials.gov/study/NCT07441408" }, { "nct_id": "NCT07372027", "title": "Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Suzhou Municipal Hospital of Anhui Province", "conditions": [ "Hemodialysis Access", "Arteriovenous Fistula", "Arteriovenous Fistula Cannulation", "Vascular Access" ], "sites": [ "Suzhou" ], "enrollment": 100, "start_date": "2026-12-15", "registry_url": "https://clinicaltrials.gov/study/NCT07372027" }, { "nct_id": "NCT07789015", "title": "A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Boehringer Ingelheim", "conditions": [ "Idiopathic Inflammatory Myopathies" ], "sites": [ "Beijing", "Chongqing", "Dongguan", "Guangzhou", "Hefei", "Luoyang", "Nanchang", "Nanjing" ], "enrollment": 270, "start_date": "2026-12-14", "registry_url": "https://clinicaltrials.gov/study/NCT07789015" }, { "nct_id": "NCT07888335", "title": "Efficacy and Safety of Obinutuzumab Beta in Primary IgA Nephropathy With Active Pathological Lesions", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Primary IgA Nephropathy" ], "sites": [ "Shanghai" ], "enrollment": 20, "start_date": "2026-12-10", "registry_url": "https://clinicaltrials.gov/study/NCT07888335" }, { "nct_id": "NCT07747090", "title": "A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH.", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": [ "Paroxysmal Nocturnal Hemoglobinuria" ], "sites": [ "Tianjin" ], "enrollment": 90, "start_date": "2026-12-10", "registry_url": "https://clinicaltrials.gov/study/NCT07747090" }, { "nct_id": "NCT07802756", "title": "Dose-Escalation/Expansion Study of iMagic in Relapsed/Refractory Hematologic Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Suzhou Immunofoco Biotechnology Co., Ltd", "conditions": [ "Relapsed/Refractory Hematologic Malignancies" ], "sites": [ "Beijing" ], "enrollment": 30, "start_date": "2026-12-10", "registry_url": "https://clinicaltrials.gov/study/NCT07802756" }, { "nct_id": "NCT07294872", "title": "A Study of TIL in Advanced Solid Tumors (CZ)", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shanghai Juncell Therapeutics", "conditions": [ "Solid Tumor, Adult" ], "sites": [ "Chengdu" ], "enrollment": 30, "start_date": "2026-12-08", "registry_url": "https://clinicaltrials.gov/study/NCT07294872" }, { "nct_id": "NCT07901842", "title": "Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Hangzhou" ], "enrollment": 826, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07901842" }, { "nct_id": "NCT07707947", "title": "Selumetinib for NF2-Related Schwannomatosis", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Beijing Tiantan Hospital", "conditions": [ "Neurofibromatosis Type 2", "NF2", "NF2-related Schwannomatosis", "Meningioma" ], "sites": [ "Beijing" ], "enrollment": 20, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07707947" }, { "nct_id": "NCT07903636", "title": "QLS4131 for Relapsed/Refractory Multiple Myeloma With Extramedullary Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": [ "Multiple Myeloma (MM)" ], "sites": [ "Tianjin" ], "enrollment": 55, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07903636" }, { "nct_id": "NCT07751497", "title": "A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Vestibular Migraine" ], "sites": [ "Hangzhou" ], "enrollment": 400, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07751497" }, { "nct_id": "NCT07866612", "title": "Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "West China Hospital", "conditions": [ "Hepatocellular Carcinoma" ], "sites": [ "Beijing", "Chengdu", "Chongqing", "Fuzhou", "Guangzhou", "Nanjing", "Shanghai" ], "enrollment": 60, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07866612" }, { "nct_id": "NCT07908303", "title": "Integrating Wearable Monitoring and Clinical Data for Stroke Early Warning", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Affiliated Hospital of Nantong University", "conditions": [ "Stroke", "Ischemic Stroke", "Recurrent Stroke", "Transient Ischemic Attack" ], "sites": [ "Nantong" ], "enrollment": 5000, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07908303" }, { "nct_id": "NCT07754825", "title": "A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Pharmaceuticals Holding Co., Ltd", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Beijing" ], "enrollment": 300, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07754825" }, { "nct_id": "NCT07920133", "title": "Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sir Run Run Shaw Hospital", "conditions": [ "Coronary Artery Disease", "Atherosclerotic Cardiovascular Disease (ASCVD)", "Residual Inflammatory Risk" ], "sites": [ "Hangzhou" ], "enrollment": 1768, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07920133" }, { "nct_id": "NCT07901946", "title": "Laryngotracheal Lesions in Adults With Long-Term Tracheostomy", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Hongying Jiang, MD", "conditions": [ "Laryngotracheal Lesions", "Tracheostomy Complications", "Tracheal Stenosis", "Tracheomalacia" ], "sites": [ "Beijing" ], "enrollment": 220, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07901946" }, { "nct_id": "NCT07782346", "title": "Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "National Health Research Institutes, Taiwan", "conditions": [ "Advanced Solid Malignancies" ], "sites": [], "enrollment": 44, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07782346" }, { "nct_id": "NCT07857343", "title": "CardioFlow Transcatheter Mitral Valve Replacement System Pre-market Clinical Investigation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai MicroPort CardioFlow Medtech Co., Ltd.", "conditions": [ "Degenerative Mitral Regurgitation" ], "sites": [ "Beijing", "Kunming", "Zhengzhou" ], "enrollment": 152, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07857343" }, { "nct_id": "NCT07718659", "title": "ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Qianfoshan Hospital", "conditions": [ "Parkinson's Disease (PD)", "Parkinsonian Disorders" ], "sites": [ "Jinan" ], "enrollment": 8, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07718659" }, { "nct_id": "NCT07918781", "title": "Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "China National Center for Cardiovascular Diseases", "conditions": [ "Postoperative Atrial Fibrillation", "Coronary Artery Disease" ], "sites": [ "Beijing", "Guangzhou", "Zhenzhou", "Changsha", "Nanjing" ], "enrollment": 1470, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07918781" }, { "nct_id": "NCT07789184", "title": "Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Hua Huang, MD, PhD", "conditions": [ "Gastric Cancer", "Peritoneal Metastasis" ], "sites": [ "Beijing", "Chongqing", "Zhangzhou", "Guangzhou", "Wuhan", "Nanjing", "Nantong", "Nanchang" ], "enrollment": 170, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07789184" }, { "nct_id": "NCT05917418", "title": "Nutritional Support on Outcomes and Cost-effectiveness for Patients at Risk", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking Union Medical College", "conditions": [ "Malnutrition" ], "sites": [ "Beijing" ], "enrollment": 400, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT05917418" }, { "nct_id": "NCT07922044", "title": "Development and Preliminary Validation of Intelligent Video Laryngoscope for Emergency Use", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Critically Ill Patients Requiring Mechanical Ventilation" ], "sites": [ "Hangzhou", "Shaoxing" ], "enrollment": 120, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07922044" }, { "nct_id": "NCT07869524", "title": "IMPT Versus IMRT for Diffuse Intrinsic Pontine Glioma", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Shandong Cancer Hospital and Institute", "conditions": [ "Diffuse Intrinsic Pontine Gliomas (DIPG)" ], "sites": [ "Jinan" ], "enrollment": 142, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07869524" }, { "nct_id": "NCT07726095", "title": "Traditional Chinese Medicine in Multidrug-Resistant Bacterial Pneumonia", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Henan University of Traditional Chinese Medicine", "conditions": [ "Multi Drug Resistant Infections", "Pneumnia" ], "sites": [ "Zhengzhou" ], "enrollment": 652, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07726095" }, { "nct_id": "NCT07575724", "title": "Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Primary", "Sarcoma" ], "sites": [ "Hangzhou" ], "enrollment": 3300, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07575724" }, { "nct_id": "NCT07796412", "title": "IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "China National Center for Cardiovascular Diseases", "conditions": [ "Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)" ], "sites": [ "Beijing" ], "enrollment": 150, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07796412" }, { "nct_id": "NCT07903857", "title": "SND002 Cell Injection in Participants With Advanced Malignant Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Guizhou Sinorda Pharmaceutical Co., Ltd.", "conditions": [ "Colorectal Neoplasms", "Stomach Neoplasms", "Solid Tumor Malignancies" ], "sites": [ "Guiyang", "Hangzhou" ], "enrollment": 78, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07903857" }, { "nct_id": "NCT07855848", "title": "AI-Assisted Precision Hyperbaric Oxygen Therapy Based on Dynamic BIS-EEG Feedback for Patients With Disorders of Consciousness", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.", "conditions": [ "Disorders of Consciousness", "Vegetative State", "Minimally Conscious State" ], "sites": [ "Shenzhen" ], "enrollment": 200, "start_date": "2026-12-01", "registry_url": "https://clinicaltrials.gov/study/NCT07855848" }, { "nct_id": "NCT07896005", "title": "A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.", "conditions": [ "Non Small Cell Lung Cancer" ], "sites": [ "Shanghai", "Hangzhou" ], "enrollment": 436, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07896005" }, { "nct_id": "NCT07885293", "title": "A Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu Hansoh Pharmaceutical Co., Ltd.", "conditions": [ "Chronic Myeloid Leukemia" ], "sites": [ "Wuhan" ], "enrollment": 408, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07885293" }, { "nct_id": "NCT07808502", "title": "Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Chengdu University of Traditional Chinese Medicine", "conditions": [ "Diabetic Foot Ulcer", "Damp-Heat Toxins Accumulation Syndrome" ], "sites": [ "Chengdu" ], "enrollment": 120, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07808502" }, { "nct_id": "NCT07881432", "title": "A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Eli Lilly and Company", "conditions": [ "Obesity" ], "sites": [ "Beijing", "Changchun", "Changsha", "Chengdu", "Chongqing", "Guangzhou", "Hefei", "Jinan" ], "enrollment": 2115, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07881432" }, { "nct_id": "NCT07883057", "title": "Comparison of Operative Hysteroscopy and Vacuum Aspiration for Terminating First-trimester Pregnancy With Intrauterine Adhesions", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Women's Hospital School Of Medicine Zhejiang University", "conditions": [ "Pregnancy Complicated With Intrauterine Adhesion" ], "sites": [ "Hangzhou" ], "enrollment": 360, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07883057" }, { "nct_id": "NCT07280429", "title": "Baduanjin Rehabilitation for Functional Restoration in ICI-Associated Myocarditis", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "China-Japan Friendship Hospital", "conditions": [ "Immune Checkpoint Inhibitors Related Myocarditis" ], "sites": [ "Beijing" ], "enrollment": 60, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07280429" }, { "nct_id": "NCT07896655", "title": "Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Guangdong Second Provincial General Hospital", "conditions": [ "Acute Ischemic Stroke", "Basilar Artery Occlusion" ], "sites": [ "Hefei", "Guangzhou" ], "enrollment": 818, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07896655" }, { "nct_id": "NCT07908992", "title": "Intertransverse Process Block Versus Erector Spinae Plane Block for Postoperative Analgesia After Percutaneous Nephrolithotomy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Tsinghua Chang Gung Hospital", "conditions": [ "Kidney Stones, Urolithiasis, Hypocitraturia", "Pain, Postoperative" ], "sites": [ "Beijing" ], "enrollment": 140, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07908992" }, { "nct_id": "NCT07189793", "title": "Toripalimab \u00b1 Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": [ "Urinary Bladder Neoplasms", "Carcinoma, Transitional Cell", "Carcinoma in Situ of Bladder", "Non-Muscle-Invasive Bladder Cancer" ], "sites": [ "Wenzhou" ], "enrollment": 106, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07189793" }, { "nct_id": "NCT07918053", "title": "A Prospective Study of Rimegepant for Short-term Preventive Treatment of Night-shift-related Migraine in Healthcare Professionals", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Chinese PLA General Hospital", "conditions": [ "Migraine Disorders" ], "sites": [ "Beijing" ], "enrollment": 260, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07918053" }, { "nct_id": "NCT07917923", "title": "A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Refractory Generalized Myasthenia Gravis", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Daishi Tian", "conditions": [ "Generalized Myasthenia Gravis (gMG)" ], "sites": [ "Wuhan" ], "enrollment": 12, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07917923" }, { "nct_id": "NCT07891377", "title": "HEC53856 Tablets for Chemotherapy-induced Anemia in Non-myeloid Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sunshine Lake Pharma Co., Ltd.", "conditions": [ "Chemotherapy-induced Anemia", "Non-Myeloid Malignancy" ], "sites": [ "Shanghai" ], "enrollment": 160, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07891377" }, { "nct_id": "NCT07890324", "title": "A Phase II Clinical Study Evaluating the Efficacy and Safety of SXRN Injection in Patients With Cancer Cachexia", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Jiangsu Guiqiong Pharmaceutical Co., Ltd.", "conditions": [ "Cachexia-Anorexia Syndrome", "Cachexia; Cancer" ], "sites": [ "Beijing" ], "enrollment": 96, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07890324" }, { "nct_id": "NCT07815301", "title": "Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": [ "Obstructive Hypertrophic Cardiomyopathy (oHCM)" ], "sites": [ "Wenzhou" ], "enrollment": 286, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07815301" }, { "nct_id": "NCT07910903", "title": "Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Keymed Biosciences Co.Ltd", "conditions": [ "Multiple Myeloma (MM)" ], "sites": [ "Tianjin" ], "enrollment": 320, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07910903" }, { "nct_id": "NCT07790861", "title": "A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Eli Lilly and Company", "conditions": [ "Obesity", "Overweight" ], "sites": [ "Chengdu", "Guangzhou", "Hangzhou", "Harbin", "Hefei", "Jinan", "Luoyang Shi", "Nanchang" ], "enrollment": 192, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07790861" }, { "nct_id": "NCT07900633", "title": "A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Eli Lilly and Company", "conditions": [ "Obesity", "Overweight", "Cardiovascular Diseases", "Diabetes Mellitus, Type 2" ], "sites": [ "Beijing", "Chengdu", "Guangzhou", "Hangzhou", "Harbin", "Jinan", "Liaoyou", "Luoyang Shi" ], "enrollment": 3000, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07900633" }, { "nct_id": "NCT07901764", "title": "MYTP01 for Immune-Mediated Diseases", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Zhejiang Provincial People's Hospital", "conditions": [ "IgA Nephropathy", "Kidney Transplant Recipients", "Lupus Nephritis", "Primary Membranous Nephropathy" ], "sites": [ "Hangzhou" ], "enrollment": 160, "start_date": "2026-12", "registry_url": "https://clinicaltrials.gov/study/NCT07901764" }, { "nct_id": "NCT07918625", "title": "A Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "BrightGene Bio-Medical Technology Co., Ltd.", "conditions": [ "Overweight or Obese Participants Without Diabetes" ], "sites": [ "Changsha" ], "enrollment": 160, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07918625" }, { "nct_id": "NCT07912671", "title": "Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular Health Management", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "China National Center for Cardiovascular Diseases", "conditions": [ "Chronic Coronary Syndrome" ], "sites": [ "Beijing" ], "enrollment": 400, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07912671" }, { "nct_id": "NCT07885904", "title": "Preventive Effectiveness of Primary Care Physician-led CGM-supported Comprehensive Intervention on Cardio-metabolic-immune Diseases in Community Patients With Type 2 Diabetes (Community Diabetes Control Project)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Xiangya Hospital of Central South University", "conditions": [ "Type 2 Diabetes Mellitus" ], "sites": [ "Changsha" ], "enrollment": 15400, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07885904" }, { "nct_id": "NCT07911579", "title": "A Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in Subjects With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.", "conditions": [ "Advanced Solid Tumors" ], "sites": [ "Tianjin" ], "enrollment": 154, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07911579" }, { "nct_id": "NCT07895992", "title": "SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.", "conditions": [ "Non-squamous Non-small Cell Lung Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 490, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07895992" }, { "nct_id": "NCT07709585", "title": "Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Guangzhou University of Traditional Chinese Medicine", "conditions": [ "Advanced Non-small Cell Lung Cancer (NSCLC)", "EGFR Exon 19 Deletion Mutation", "EGFR Exon 21 Mutation", "EGFR Exon 21 L858R Mutation" ], "sites": [ "Guangzhou" ], "enrollment": 124, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07709585" }, { "nct_id": "NCT07887490", "title": "Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy Volunteers", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Lee's Pharmaceutical Limited", "conditions": [ "Healthy Volunteers" ], "sites": [ "Hefei" ], "enrollment": 36, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07887490" }, { "nct_id": "NCT07897136", "title": "CLL-1/CD70 Dual-Target CAR-T Cell Therapy for Acute Myeloid Leukemia", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Liping Dou", "conditions": [ "Acute Myeloid Leukemia (AML)", "Relapsed/Refractory Acute Myeloid Leukemia" ], "sites": [ "Beijing" ], "enrollment": 12, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07897136" }, { "nct_id": "NCT07901569", "title": "Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Liu Zhuo", "conditions": [ "Carcinoma, Renal Cell", "Inferior Vena Cava Tumor Thrombus" ], "sites": [ "Beijing" ], "enrollment": 273, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07901569" }, { "nct_id": "NCT07714447", "title": "Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "CRC (Colorectal Cancer)", "BRAF" ], "sites": [ "Guangzhou" ], "enrollment": 91, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07714447" }, { "nct_id": "NCT07892872", "title": "Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Capital Medical University", "conditions": [ "Respiratory Viral Infections", "Influenza", "SARS CoV 2 Infection" ], "sites": [ "Beijing" ], "enrollment": 618, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07892872" }, { "nct_id": "NCT07917182", "title": "Chinese University-Alzheimer's Disease With Vascular and Other Co-pathology: Towards Actionable Neuro-Cognitive-Omic Evaluations (CU-ADVANCE)", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Chinese University of Hong Kong", "conditions": [ "Alzheimer s Disease", "Mild Cognitive Impairment (MCI)" ], "sites": [ "Hong Kong" ], "enrollment": 1600, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07917182" }, { "nct_id": "NCT07916844", "title": "Hepatic Arterial Infusion Chemotherapy Versus Capecitabine as Adjuvant Therapy for Resected Biliary Tract Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Zhai Wenlong", "conditions": [ "Biliary Tract Cancer", "Cholangiocarcinoma", "Gallbladder Cancer" ], "sites": [ "Zhengzhou" ], "enrollment": 90, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07916844" }, { "nct_id": "NCT07353749", "title": "Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Duan Chuanzhi", "conditions": [ "Unruptured Intracranial Aneurysms", "Cerebrovascular Event", "Hemorrhagic Stroke", "Methylprednisolone" ], "sites": [ "Guangzhou" ], "enrollment": 864, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07353749" }, { "nct_id": "NCT07871214", "title": "A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Bristol-Myers Squibb", "conditions": [ "Early-Stage Non-Small Cell Lung Cancer" ], "sites": [ "Changsha Shi", "Shanghai", "Chengdu", "Beijing" ], "enrollment": 80, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07871214" }, { "nct_id": "NCT07865910", "title": "A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Shanghai Henlius Biotech", "conditions": [ "NSCLC (Advanced Non-small Cell Lung Cancer)" ], "sites": [ "Hefei", "Beijing", "Chongqing", "Nanning", "Zunyi", "Shijiazhuang", "Harbin", "Anyang" ], "enrollment": 1438, "start_date": "2026-11-30", "registry_url": "https://clinicaltrials.gov/study/NCT07865910" }, { "nct_id": "NCT07922798", "title": "A Phase I Clinical Trial of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of UBT48128 Tablets in Healthy Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "The United Bio-Technology (Hengqin) Co., Ltd.", "conditions": [ "Overweight , Obesity" ], "sites": [ "Changsha" ], "enrollment": 60, "start_date": "2026-11-29", "registry_url": "https://clinicaltrials.gov/study/NCT07922798" }, { "nct_id": "NCT07893171", "title": "Study of CM529D1 in Participants With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Keymed Biosciences Co.Ltd", "conditions": [ "Advanced Solid Tumors" ], "sites": [ "Shanghai" ], "enrollment": 128, "start_date": "2026-11-27", "registry_url": "https://clinicaltrials.gov/study/NCT07893171" }, { "nct_id": "NCT07917468", "title": "Sintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": [ "Locally Advanced Rectal Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 500, "start_date": "2026-11-25", "registry_url": "https://clinicaltrials.gov/study/NCT07917468" }, { "nct_id": "NCT06946277", "title": "Assessing the Time-Course of Dexmedetomidine-Induced Analgesia Via EEG", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "China International Neuroscience Institution", "conditions": [ "Total Hip Arthroplasty (THA)", "Intrathecal Anesthesia", "Hip Osteoarthritis" ], "sites": [ "Beijing" ], "enrollment": 20, "start_date": "2026-11-25", "registry_url": "https://clinicaltrials.gov/study/NCT06946277" }, { "nct_id": "NCT07911670", "title": "Exploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease", "status": "RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "The First Affiliated Hospital of Anhui Medical University", "conditions": [ "PARKINSON DISEASE (Disorder)" ], "sites": [ "Hefei" ], "enrollment": 12, "start_date": "2026-11-23", "registry_url": "https://clinicaltrials.gov/study/NCT07911670" }, { "nct_id": "NCT07894328", "title": "A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": [ "Breast Cancer" ], "sites": [ "Tianjin" ], "enrollment": 1050, "start_date": "2026-11-20", "registry_url": "https://clinicaltrials.gov/study/NCT07894328" }, { "nct_id": "NCT07263867", "title": "Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "LanZhou University", "conditions": [ "Colonoscopy", "Bowel Preparation", "Quality of Healthcare" ], "sites": [ "Lanzhou" ], "enrollment": 300, "start_date": "2026-11-20", "registry_url": "https://clinicaltrials.gov/study/NCT07263867" }, { "nct_id": "NCT07920640", "title": "Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Beijing Supreme Life Pharmaceutical Technology Co., Ltd.", "conditions": [ "Diabetes Mellitus, Type 2" ], "sites": [ "Beijing" ], "enrollment": 150, "start_date": "2026-11-20", "registry_url": "https://clinicaltrials.gov/study/NCT07920640" }, { "nct_id": "NCT07914660", "title": "Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.", "conditions": [ "Hyperlipoproteinemia (a)" ], "sites": [ "Beijing" ], "enrollment": 192, "start_date": "2026-11-20", "registry_url": "https://clinicaltrials.gov/study/NCT07914660" }, { "nct_id": "NCT07913048", "title": "A Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Hunan Kelun Pharmaceutical Co., Ltd.", "conditions": [ "Healthy Participants" ], "sites": [ "Changsha" ], "enrollment": 20, "start_date": "2026-11-20", "registry_url": "https://clinicaltrials.gov/study/NCT07913048" }, { "nct_id": "NCT07453836", "title": "Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "China Immunotech (Beijing) Biotechnology Co., Ltd.", "conditions": [ "Autoimmune Hemolytic Anemia" ], "sites": [ "Beijing" ], "enrollment": 13, "start_date": "2026-11-18", "registry_url": "https://clinicaltrials.gov/study/NCT07453836" }, { "nct_id": "NCT07902804", "title": "A Study of IBI3043 Treatment in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": [ "Solid Tumors" ], "sites": [ "Guangzhou" ], "enrollment": 604, "start_date": "2026-11-16", "registry_url": "https://clinicaltrials.gov/study/NCT07902804" }, { "nct_id": "NCT07720193", "title": "A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Nanjing Leads Biolabs Co.,Ltd", "conditions": [ "Advanced Extrapulmonary Neuroendocrine Carcinoma" ], "sites": [ "Bengbu", "Beijing", "Chongqing", "Fuzhou", "Xiamen", "Lanzhou", "Guangzhou", "Nanning" ], "enrollment": 280, "start_date": "2026-11-16", "registry_url": "https://clinicaltrials.gov/study/NCT07720193" }, { "nct_id": "NCT07759232", "title": "Effects of Exercise Snacks on Physical Health and Cognitive Function in Individuals With Intellectual Disabilities", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "University of Macau", "conditions": [ "Intellectual Disability" ], "sites": [ "Hangzhou" ], "enrollment": 24, "start_date": "2026-11-16", "registry_url": "https://clinicaltrials.gov/study/NCT07759232" }, { "nct_id": "NCT07909863", "title": "Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": [ "Small Cell Lung Cancer (SCLC)", "SCLC, Extensive Stage" ], "sites": [ "Tianjin" ], "enrollment": 25, "start_date": "2026-11-15", "registry_url": "https://clinicaltrials.gov/study/NCT07909863" }, { "nct_id": "NCT07878091", "title": "A Phase 2a Study of Kylo-0603 Capsule in Participants With Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.", "conditions": [ "Metabolic Dysfunction-Associated Steatoic Liver Disease" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2026-11-15", "registry_url": "https://clinicaltrials.gov/study/NCT07878091" }, { "nct_id": "NCT07815210", "title": "Phase I Trial of HHK101 in Patients With Schizophrenia", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.", "conditions": [ "Schizophrenia" ], "sites": [ "Changsha", "Xi'an", "Shanghai", "Huzhou" ], "enrollment": 88, "start_date": "2026-11-15", "registry_url": "https://clinicaltrials.gov/study/NCT07815210" }, { "nct_id": "NCT07803705", "title": "Efficacy of Mazdutide on Fatty Pancreas", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Tongji Hospital", "conditions": [ "Fatty Pancreas", "Overweight", "Obesity" ], "sites": [ "Wuhan" ], "enrollment": 194, "start_date": "2026-11-15", "registry_url": "https://clinicaltrials.gov/study/NCT07803705" }, { "nct_id": "NCT07774728", "title": "Hearing Intervention Effects on Brain and Language Development in Children With Bilateral Mild Hearing Loss", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": [ "Hearing Loss, Bilateral" ], "sites": [ "Foshan", "Guangzhou", "Jiangyin", "Kunming", "Liuzhou", "Nanjing", "Shanghai", "Sichuan" ], "enrollment": 260, "start_date": "2026-11-15", "registry_url": "https://clinicaltrials.gov/study/NCT07774728" }, { "nct_id": "NCT07904533", "title": "Efficacy and Safety of Minocycline Add-on in Patients With Neurosyphilis", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Beijing Ditan Hospital", "conditions": [ "Neurosyphilis" ], "sites": [ "Beijing" ], "enrollment": 778, "start_date": "2026-11-15", "registry_url": "https://clinicaltrials.gov/study/NCT07904533" }, { "nct_id": "NCT07916194", "title": "A Study of Zovaglutide (ZT002 Injection) in Participants With Hepatic Impairment and Healthy Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Beijing QL Biopharmaceutical Co.,Ltd", "conditions": [ "Overweight, Obesity" ], "sites": [ "Chongqing", "Zhengzhou", "Chengdu" ], "enrollment": 24, "start_date": "2026-11-13", "registry_url": "https://clinicaltrials.gov/study/NCT07916194" }, { "nct_id": "NCT07917039", "title": "SYH2072 Tablets in Participants With Primary Aldosteronism", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "InnovStone Therapeutics Limited", "conditions": [ "Primary Aldosteronism" ], "sites": [ "Jinan" ], "enrollment": 60, "start_date": "2026-11-13", "registry_url": "https://clinicaltrials.gov/study/NCT07917039" }, { "nct_id": "NCT07830095", "title": "5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Chest Hospital", "conditions": [ "Lung Cancer" ], "sites": [ "Shanghai" ], "enrollment": 15, "start_date": "2026-11-13", "registry_url": "https://clinicaltrials.gov/study/NCT07830095" }, { "nct_id": "NCT07881991", "title": "Phase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection.", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "CSPC Ouyi Pharmaceutical Co., Ltd.", "conditions": [ "Respiratory Syncytial Virus Infections" ], "sites": [ "Beijing" ], "enrollment": 80, "start_date": "2026-11-13", "registry_url": "https://clinicaltrials.gov/study/NCT07881991" }, { "nct_id": "NCT07637721", "title": "Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Zhejiang University", "conditions": [ "Choledocholithiasis With Cholecystitis With Obstruction", "Obstructive Jaundice", "Pancreatitis", "Cholelithiasis" ], "sites": [ "Tianjin", "Hangzhou" ], "enrollment": 410, "start_date": "2026-11-12", "registry_url": "https://clinicaltrials.gov/study/NCT07637721" }, { "nct_id": "NCT07783100", "title": "Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid Leukemia", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "The First Affiliated Hospital of Xiamen University", "conditions": [ "Relapsed or Refractory Acute Myeloid Leukemia" ], "sites": [ "Xiamen" ], "enrollment": 30, "start_date": "2026-11-11", "registry_url": "https://clinicaltrials.gov/study/NCT07783100" }, { "nct_id": "NCT07917949", "title": "Zemetostat With Anlotinib in Patients With Recurrent/Metastatic Head and Neck Soft Tissue Sarcoma", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": [ "Soft Tissue Sarcoma" ], "sites": [ "Shanghai" ], "enrollment": 34, "start_date": "2026-11-10", "registry_url": "https://clinicaltrials.gov/study/NCT07917949" }, { "nct_id": "NCT07768137", "title": "Transcranial Direct Current Stimulation for Neurogenic Overactive Bladder Symptoms Among People With Stroke", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Hong Kong Polytechnic University", "conditions": [ "Stroke", "Neurogenic Overactive Bladder" ], "sites": [ "Hong Kong" ], "enrollment": 60, "start_date": "2026-11-10", "registry_url": "https://clinicaltrials.gov/study/NCT07768137" }, { "nct_id": "NCT07920172", "title": "Clinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells)", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.", "conditions": [ "Herpes Zoster" ], "sites": [ "Guangxi" ], "enrollment": 500, "start_date": "2026-11-10", "registry_url": "https://clinicaltrials.gov/study/NCT07920172" }, { "nct_id": "NCT07922902", "title": "Automated Radiation Target Contouring and Treatment Planning Via RATA: A Multi-Center RCT", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "zhaoxiaohui", "conditions": [ "Cancer", "Malignant Neoplasms", "Radiotherapy" ], "sites": [ "Guangzhou" ], "enrollment": 62, "start_date": "2026-11-09", "registry_url": "https://clinicaltrials.gov/study/NCT07922902" }, { "nct_id": "NCT07730346", "title": "Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged \u22652 Years.", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Nanjing Zenshine Pharmaceuticals", "conditions": [ "Influenza Prevention" ], "sites": [ "Beijing" ], "enrollment": 858, "start_date": "2026-11-07", "registry_url": "https://clinicaltrials.gov/study/NCT07730346" }, { "nct_id": "NCT07796477", "title": "A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "CSPC Ouyi Pharmaceutical Co., Ltd.", "conditions": [ "T2DM (Type 2 Diabetes Mellitus)" ], "sites": [ "Nanjing" ], "enrollment": 240, "start_date": "2026-11-06", "registry_url": "https://clinicaltrials.gov/study/NCT07796477" }, { "nct_id": "NCT07890441", "title": "Pregnancy Anti-inflammatory Diet Intervention Study", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Capital Medical University", "conditions": [ "Pregnancy", "Dietary Inflammatory Index (DII)" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2026-11-05", "registry_url": "https://clinicaltrials.gov/study/NCT07890441" }, { "nct_id": "NCT07920783", "title": "A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Gan & Lee Pharmaceuticals.", "conditions": [ "Atopic Dermatitis" ], "sites": [ "Beijing" ], "enrollment": 124, "start_date": "2026-11-05", "registry_url": "https://clinicaltrials.gov/study/NCT07920783" }, { "nct_id": "NCT07339774", "title": "Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "West China Hospital", "conditions": [ "Radiotherapy-induced Oral Mucositis" ], "sites": [ "Chengdu" ], "enrollment": 128, "start_date": "2026-11-05", "registry_url": "https://clinicaltrials.gov/study/NCT07339774" }, { "nct_id": "NCT07255612", "title": "Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negative Breast Cancer)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Breast Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 29, "start_date": "2026-11-04", "registry_url": "https://clinicaltrials.gov/study/NCT07255612" }, { "nct_id": "NCT07911787", "title": "Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu Hansoh Pharmaceutical Co., Ltd.", "conditions": [ "SCHIZOPHRENIA 1 (Disorder)" ], "sites": [ "Shanghai" ], "enrollment": 476, "start_date": "2026-11-04", "registry_url": "https://clinicaltrials.gov/study/NCT07911787" }, { "nct_id": "NCT07914790", "title": "Epidural Hydroxyethyl Starch for Post-Dural Puncture Headache in Parturients", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Peking University First Hospital", "conditions": [ "Parturients", "Accidental Puncture of Dura During Anaesthesia", "Epidural Filling", "Hydroxyethyl Starch" ], "sites": [ "Beijing", "Yinchuan", "Taiyuan" ], "enrollment": 410, "start_date": "2026-11-04", "registry_url": "https://clinicaltrials.gov/study/NCT07914790" }, { "nct_id": "NCT07629583", "title": "To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Genentech, Inc.", "conditions": [ "Lupus Erythematosus, Systemic" ], "sites": [ "Beijing", "Pingxiang" ], "enrollment": 46, "start_date": "2026-11-02", "registry_url": "https://clinicaltrials.gov/study/NCT07629583" }, { "nct_id": "NCT07904260", "title": "Effect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High Risk for Obstructive Sleep Apnea Syndrome in High-altitude Regions", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Diansan Su", "conditions": [ "Hypoxemia", "Gastric Cancer (Diagnosis)", "Esophageal Cancer", "High-altitude Illness" ], "sites": [ "Sanjiaocheng", "Xining", "Hangzhou" ], "enrollment": 430, "start_date": "2026-11-02", "registry_url": "https://clinicaltrials.gov/study/NCT07904260" }, { "nct_id": "NCT07850063", "title": "ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Boehringer Ingelheim", "conditions": [ "Obesity", "Metabolic Dysfunction-associated Steatotic Liver Disease" ], "sites": [ "Chengdu", "Luoyang", "Nanjing", "Shanghai" ], "enrollment": 600, "start_date": "2026-11-02", "registry_url": "https://clinicaltrials.gov/study/NCT07850063" }, { "nct_id": "NCT07920692", "title": "Integrated Medicine for Sepsis: An RCT With Phenotyping", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Henan University of Traditional Chinese Medicine", "conditions": [ "Sepsis" ], "sites": [ "Zhengzhou" ], "enrollment": 320, "start_date": "2026-11-02", "registry_url": "https://clinicaltrials.gov/study/NCT07920692" }, { "nct_id": "NCT07885319", "title": "Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Malignant Pleural Mesothelioma, Advanced" ], "sites": [ "Shanghai", "Chengdu" ], "enrollment": 78, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07885319" }, { "nct_id": "NCT07901218", "title": "Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Diminished Ovarian Reserve", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University Third Hospital", "conditions": [ "Diminished Ovarian Reserve (DOR)" ], "sites": [ "Guangzhou", "Beijing", "Ningxia", "Shanghai" ], "enrollment": 260, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07901218" }, { "nct_id": "NCT07892508", "title": "Adding Preoperative Radiotherapy Based on Early Treatment Response in Breast Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Invasive Breast Cancer" ], "sites": [ "Hangzhou", "Yiwu" ], "enrollment": 200, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07892508" }, { "nct_id": "NCT07859462", "title": "Phase I Study of In Vivo CAR-Tumor Technology for the Treatment of Advanced Malignant Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": [ "Advanced Solid Tumor" ], "sites": [ "Beijing" ], "enrollment": 27, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07859462" }, { "nct_id": "NCT07828327", "title": "Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Qianfoshan Hospital", "conditions": [ "Allergic Bronchopulmonary Aspergillosis", "ABPA", "Severe Eosinophilic Asthma" ], "sites": [ "Jinan" ], "enrollment": 10, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07828327" }, { "nct_id": "NCT07912268", "title": "Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Jiangsu Simcere Pharmaceutical Co., Ltd.", "conditions": [ "ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer" ], "sites": [ "Fuzhou", "Harbin", "Changsha", "Nanchang", "Changchun", "Shanghai", "Taizhou" ], "enrollment": 270, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07912268" }, { "nct_id": "NCT07920055", "title": "Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sir Run Run Shaw Hospital", "conditions": [ "Coronary In-stent Restenosis", "Coronary Artery Disease" ], "sites": [ "Hangzhou" ], "enrollment": 106, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07920055" }, { "nct_id": "NCT07919717", "title": "NIVO+IPI Neoadjuvant Therapy for Recurrent Resectable HCC", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Zhongshan Hospital", "conditions": [ "Hepatocellular Carcinoma (HCC)", "Recurrent Hepatocellular Cancer" ], "sites": [ "Shanghai" ], "enrollment": 35, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07919717" }, { "nct_id": "NCT07886450", "title": "Oculomotor-Pupillary AI Biomarkers in Parkinson's", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "The Hong Kong Polytechnic University", "conditions": [ "PARKINSON DISEASE (Disorder)" ], "sites": [ "Zhengzhou" ], "enrollment": 128, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07886450" }, { "nct_id": "NCT07829952", "title": "Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "The First Affiliated Hospital of Henan University of Science and Technology", "conditions": [ "Thrombocytopenia", "Allogeneic Hematopoietic Stem Cell Transplantation" ], "sites": [ "Luoyang" ], "enrollment": 87, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07829952" }, { "nct_id": "NCT07873203", "title": "Delayed Morning Training, Sleep, and Change-of-Direction Performance in Badminton Athletes", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Capital University of Physical Education and Sports, China", "conditions": [ "Sleep Duration", "Athletic Performance" ], "sites": [ "Beijing" ], "enrollment": 38, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07873203" }, { "nct_id": "NCT07725484", "title": "Efficacy of Lipoic Acid on Chronic Ischemic Heart Failure Patients", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Shanghai Zhongshan Hospital", "conditions": [ "Heart Failure Due to Coronary Artery Disease" ], "sites": [ "Hefei", "Fuzhou", "Guangzhou", "Luoyang", "Zhengzhou", "Nanjing", "Dalian", "Xi'an" ], "enrollment": 1188, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07725484" }, { "nct_id": "NCT07873086", "title": "MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLC", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Non-Small Cell Lung Cancer" ], "sites": [ "Beijing" ], "enrollment": 50, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07873086" }, { "nct_id": "NCT07720921", "title": "Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Peking University First Hospital", "conditions": [ "Urothelial Carcinoma of the Renal Pelvis and Ureter", "Neoadjuvant Therapy" ], "sites": [ "Beijing" ], "enrollment": 20, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07720921" }, { "nct_id": "NCT07847346", "title": "China Aortic Infection and Graft Infection Study: An Ambispective Cohort", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Shanghai Zhongshan Hospital", "conditions": [ "Vascular Graft Infection", "Infectious Aortitis", "Aortoenteric Fistula" ], "sites": [ "Shanghai" ], "enrollment": 2000, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07847346" }, { "nct_id": "NCT07892001", "title": "Modified Inhaled Nitric Oxide in Ventilated Patients With Acute Respiratory Failure", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Southeast University, China", "conditions": [ "Acute Respiratory Failure (ARF)", "Nitric Oxide", "Pneumonia" ], "sites": [ "Nanjing" ], "enrollment": 424, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07892001" }, { "nct_id": "NCT07763938", "title": "CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": [ "Relapsed/Refractory B-cell Malignancies" ], "sites": [ "Nanjing" ], "enrollment": 80, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07763938" }, { "nct_id": "NCT07854145", "title": "Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": [ "Congenital Heart Disease (CHD)", "Postoperative Sleep" ], "sites": [ "Shanghai" ], "enrollment": 172, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07854145" }, { "nct_id": "NCT07912606", "title": "D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": [ "Gastric Adenocarcinoma", "Gastroesophageal Junction Adenocarcinoma" ], "sites": [ "Nanjing" ], "enrollment": 32, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07912606" }, { "nct_id": "NCT07902024", "title": "Xuanbai Yiqi Decoction for Sepsis: A Randomized Controlled Trial", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": [ "Sepsis" ], "sites": [ "Shanghai" ], "enrollment": 280, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07902024" }, { "nct_id": "NCT07632170", "title": "The Efficacy and Safety of Selinisole Combined With Azacitidine and Venetoclax in the Treatment of Newly Diagnosed High-risk Myeloid Tumors With TP53 Mutations", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Bing Han", "conditions": [ "Myeloid Tumors" ], "sites": [ "Beijing" ], "enrollment": 30, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07632170" }, { "nct_id": "NCT07886892", "title": "Computed Inspiratory Muscle Pressure to Monitor Inspiratory Effort During Pressure Support Ventilation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Jian-Xin Zhou", "conditions": [ "Mechanical Ventilation", "Critical Care" ], "sites": [ "Beijing" ], "enrollment": 30, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07886892" }, { "nct_id": "NCT07898319", "title": "Development and Prospective Validation of the AutoEIT Foundation Model for ARDS", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Ruijin Hospital", "conditions": [ "ARDS (Acute Respiratory Distress Syndrome)", "Respiratory Failure", "Mechanical Ventilation", "Ventilator-induced Lung Injury (VILI)" ], "sites": [ "Shanghai" ], "enrollment": 1200, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07898319" }, { "nct_id": "NCT07887126", "title": "Fluoroquinolone-Doxycycline Oral Treatments for Adults With Uncomplicated Brucellosis", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The First Affiliated Hospital of Shihezi University", "conditions": [ "Brucellosis" ], "sites": [ "Shihezi", "Chongqing", "Yining" ], "enrollment": 200, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07887126" }, { "nct_id": "NCT07886918", "title": "Computed Inspiratory Muscle Pressure to Monitor Inspiratory Effort During Pressure-Targeted Assist/Control Ventilation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Jian-Xin Zhou", "conditions": [ "Mechanical Ventilation", "Critical Care" ], "sites": [ "Beijing" ], "enrollment": 30, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07886918" }, { "nct_id": "NCT07872436", "title": "A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Vincentage Pharma Co., Ltd", "conditions": [ "Type 2 Diabetes Mellitus (DM)" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07872436" }, { "nct_id": "NCT07887165", "title": "Open Versus Fully Endoscopic Calcaneoplasty With Achilles Tendon Insertional Reconstruction for Haglund Syndrome", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Nanjing First Hospital, Nanjing Medical University", "conditions": [ "Haglund Syndrome", "Insertional Achilles Tendinopathy" ], "sites": [ "Nanjing" ], "enrollment": 67, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07887165" }, { "nct_id": "NCT07686770", "title": "Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Children's Hospital of Fudan University", "conditions": [ "Kawasaki Disease" ], "sites": [ "Nanchang", "Shanghai" ], "enrollment": 90, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07686770" }, { "nct_id": "NCT07890506", "title": "Chidamide Combined With Benmelstobart, Nab-paclitaxel, and SBRT as Second-Line Treatment for Advanced BTC", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School", "conditions": [ "BTC" ], "sites": [ "Nanjing" ], "enrollment": 41, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07890506" }, { "nct_id": "NCT07911605", "title": "Short-Term External Trigeminal Nerve Stimulation for Acute Ischemic Stroke: A Sham-Controlled Trial", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Xidian University", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Xi'an" ], "enrollment": 60, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07911605" }, { "nct_id": "NCT07892274", "title": "Trastuzumab Rezetecan Followed by Pyrotinib, Fulvestrant, and Dalpiciclib in HR-Positive, HER2-Positive Advanced Breast Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": [ "Metastatic Breast Cancer (MBC)", "HER2-Positive Breast Cancer", "Hormone Receptor-Positive Breast Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 226, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07892274" }, { "nct_id": "NCT07917624", "title": "Prophylactic Strategies for Mitigating Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences", "conditions": [ "Diffuse Large B-Cell Lymphoma (DLBCL)" ], "sites": [ "Beijing" ], "enrollment": 87, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07917624" }, { "nct_id": "NCT07795554", "title": "The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Second Xiangya Hospital of Central South University", "conditions": [ "Schizophrenia Spectrum", "Schizophrenia", "Antipsychotic Induced Weight Gain" ], "sites": [ "Changsha" ], "enrollment": 60, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07795554" }, { "nct_id": "NCT07885709", "title": "MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLC", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Non-Small Cell Lung Cancer (NSCLC)" ], "sites": [ "Beijing" ], "enrollment": 100, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07885709" }, { "nct_id": "NCT07887997", "title": "Temporal Interference Stimulation (TI) for Schizophrenia (SCZ)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Anhui Medical University", "conditions": [ "Schizophrenia" ], "sites": [ "Hefei" ], "enrollment": 100, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07887997" }, { "nct_id": "NCT07902713", "title": "Becotatug Vedotin Plus Gemcitabine and a PD-1 Inhibitor in Recurrent or Metastatic Nasopharyngeal Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Nasopharyngeal Carcinoma (NPC)" ], "sites": [ "Guangzhou" ], "enrollment": 30, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07902713" }, { "nct_id": "NCT07897006", "title": "Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated Coagulopathy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Jiao Tong University School of Medicine", "conditions": [ "Sepsis", "Disseminated Intravascular Coagulation (DIC)" ], "sites": [ "Shanghai" ], "enrollment": 210, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07897006" }, { "nct_id": "NCT07829276", "title": "Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia", "status": "ENROLLING_BY_INVITATION", "phase": "Observational", "lead_sponsor": "Zhejiang Provincial People's Hospital", "conditions": [ "Malignant Tumor" ], "sites": [ "Hangzhou" ], "enrollment": 350, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07829276" }, { "nct_id": "NCT07910305", "title": "Transcranial Magnetic Stimulation (TMS) for Autism Spectrum Disorder", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sir Run Run Shaw Hospital", "conditions": [ "Autism Spectrum Disorder", "TMS" ], "sites": [ "Hangzhou" ], "enrollment": 120, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07910305" }, { "nct_id": "NCT07915843", "title": "Multi-center Prospective Validation of Real-Time AI-EGGIM System", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Qilu Hospital of Shandong University", "conditions": [ "Gastric Intestinal Metaplasia" ], "sites": [ "Binzhou", "Jinan", "Qingdao" ], "enrollment": 540, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07915843" }, { "nct_id": "NCT07919470", "title": "Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Acute Lymphoblastic Leukemia", "Hematopoietic Stem Cell Transplantation" ], "sites": [ "Beijing" ], "enrollment": 180, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07919470" }, { "nct_id": "NCT07895329", "title": "Shiwei Anshen Granules for Chronic Insomnia", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Dongzhimen Hospital, Beijing", "conditions": [ "Chronic Insomnia" ], "sites": [ "Beijing" ], "enrollment": 240, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07895329" }, { "nct_id": "NCT07884903", "title": "Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Shanxi Bethune Hospital", "conditions": [ "Obesity & Overweight", "Diabetes Mellitus, Type 2", "Hypertension", "Non-alcoholic Fatty Liver Disease (MASLD)" ], "sites": [ "Taiyuan" ], "enrollment": 25974, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07884903" }, { "nct_id": "NCT07918755", "title": "Development and Validation of a Biopsy Decision Model for Nasopharyngeal Carcinoma Based on Serological Markers and Endoscopic Features", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Zhongshan People's Hospital, Guangdong, China", "conditions": [ "Nasopharyngeal Carcinoma (NPC)" ], "sites": [ "Zhongshan", "Nanning" ], "enrollment": 1500, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07918755" }, { "nct_id": "NCT07904884", "title": "MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC )", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": [ "ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION", "Acute Myeloid Leukemia" ], "sites": [ "Zhejiang" ], "enrollment": 310, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07904884" }, { "nct_id": "NCT07569575", "title": "Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "HuaMg Perfection Med Tech (Suzhou) Co., Ltd.", "conditions": [ "Tibial Fracture", "Femoral Fracture", "Humeral Fracture" ], "sites": [ "Xicheng", "Luoyang", "Shijiazhuang", "Xi'an", "Xuhui" ], "enrollment": 160, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07569575" }, { "nct_id": "NCT07913243", "title": "Small Monetary Incentives for Digital Cognitive Training Adherence in Community-Dwelling Older Adults", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Xuanwu Hospital, Beijing", "conditions": [ "Cognitive Decline", "Dementia Prevention" ], "sites": [ "Beijing", "Yangcheng" ], "enrollment": 110, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07913243" }, { "nct_id": "NCT07821606", "title": "Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Hansoh BioMedical R&D Company", "conditions": [ "Platinum-sensitive Recurrent Ovarian Cancer" ], "sites": [ "Hefei", "Beijing", "Chongqing", "Xiamen", "Guangzhou", "Shaoguan", "Nanning", "Harbin" ], "enrollment": 460, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07821606" }, { "nct_id": "NCT07847229", "title": "A Prospective, Biomarker-Stratified Phase 2 Study: \u03b2-Hydroxybutyrate as a Predictive Biomarker for Short-Course Radiotherapy Followed by Chemotherapy Plus PD-1 Inhibitor Versus Chemotherapy Alone in Locally Advanced Rectal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tao Zhang", "conditions": [ "Rectal Cancer", "Radiotherapy", "Immunotherapy", "Chemotherapy" ], "sites": [ "Wuhan" ], "enrollment": 144, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07847229" }, { "nct_id": "NCT07917078", "title": "Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "China National Center for Cardiovascular Diseases", "conditions": [ "Pulmonary Embolism" ], "sites": [ "Beijing", "Guangzhou", "Shenzhen", "Zhangjiakou", "Xinxiang", "Zhengzhou", "Wuhan", "Baotou" ], "enrollment": 270, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07917078" }, { "nct_id": "NCT07778953", "title": "90% Effective Infusion Time of Sufentanil to Prevent Induction Cough: A Biased Coin Sequential Study", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shiyou Wei", "conditions": [ "Cough" ], "sites": [ "Shaoyang" ], "enrollment": 120, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07778953" }, { "nct_id": "NCT07886775", "title": "Optical Coherence Tomography-Assisted Strategy for Interventional Management of Symptomatic Carotid Stenosis (OASIS-C)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Tiantan Hospital", "conditions": [ "Carotid Stenosis" ], "sites": [ "Beijing" ], "enrollment": 100, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07886775" }, { "nct_id": "NCT07621497", "title": "FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Metastatic Colorectal Cancer (CRC)" ], "sites": [ "Guangzhou", "Shanghai" ], "enrollment": 229, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07621497" }, { "nct_id": "NCT07879339", "title": "Multi-omics Study of Cervical Neuroendocrine Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Peking Union Medical College Hospital", "conditions": [ "Cervical Neuroendocrine Carcinoma" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07879339" }, { "nct_id": "NCT07919704", "title": "AI-Assisted Differentiation of Pancreatic Cystic Lesions Using EUS Images and Clinical Features", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Pancreatic Mucinous Cystic Neoplasm", "Pancreatic Serous Cystic Neoplasm", "Pancreatic Pseudocyst" ], "sites": [ "Shanghai" ], "enrollment": 400, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07919704" }, { "nct_id": "NCT07423728", "title": "CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": [ "Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization" ], "sites": [ "Zhengzhou", "Wuhan", "Hangzhou" ], "enrollment": 160, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07423728" }, { "nct_id": "NCT07901257", "title": "Social Software-Based Intelligent Management System for Bowel Preparation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shandong University", "conditions": [ "Colorectal Polyp", "Colorectal Adenoma", "Bowel Preparation", "Artificial Intelligence" ], "sites": [ "Jinan" ], "enrollment": 740, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07901257" }, { "nct_id": "NCT07781150", "title": "Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tongji Hospital", "conditions": [ "Obesity", "Overweight", "Atypical Endometrial Hyperplasia", "Endometrial Carcinoma Stage I" ], "sites": [ "Zhengzhou", "Wuhan", "Changchun", "Hangzhou", "Shanghai", "Tianjin" ], "enrollment": 128, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07781150" }, { "nct_id": "NCT07906730", "title": "Magnesium Alloy Scaffold With Controlled Degradation for Periarticular Bone Defects", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University Third Hospital", "conditions": [ "Periarticular Bone Defect", "Proximal Humerus Fracture", "Distal Radius Fracture", "Tibial Plateau Fracture" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07906730" }, { "nct_id": "NCT07918937", "title": "Multi-center Study of Three-Dimensional Transesophageal Echocardiography in Patients With Secondary Mitral Regurgitation", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "First Hospital of China Medical University", "conditions": [ "Mitral Valve Insufficiency" ], "sites": [ "Hefei", "Chongqing", "Fuzhou", "Zhangzhou", "Lanzhou", "Tianshui", "Guangzhou", "Shantou" ], "enrollment": 2400, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07918937" }, { "nct_id": "NCT06957587", "title": "Intelligent Classification of Intraoperative Hemodynamic Phenotypes Based on CADFlow Doppler Monitoring", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Shanghai 6th People's Hospital", "conditions": [ "Ultrasound", "Machine Learning", "Intraoperative Hypotension", "Hemodynamic Monitoring" ], "sites": [ "Shanghai" ], "enrollment": 440, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT06957587" }, { "nct_id": "NCT07829627", "title": "Positive- vs Negative-Pressure Extubation in High-Risk Patients", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Zhongshan Hospital", "conditions": [ "Positive Pressure Extubation Techniques", "Negative Pressure Extubation Techniques", "High-risk Patients Prone to Extubation Failure" ], "sites": [ "Shanghai" ], "enrollment": 96, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07829627" }, { "nct_id": "NCT07915453", "title": "Multimodal MRI Assessment of Brain Fluid Circulation in Idiopathic Intracranial Hypertension", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Beijing Tiantan Hospital", "conditions": [ "Idiopathic Intracranial Hypertension" ], "sites": [ "Beijing" ], "enrollment": 105, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07915453" }, { "nct_id": "NCT07912957", "title": "Neoadjuvant SHR-A1811 \u00b1 Adebrelimab in GC/GEJ", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fudan University", "conditions": [ "Gastric Adenocarcinoma", "Gastroesophageal Junction (GEJ) Adenocarcinoma" ], "sites": [ "Shanghai" ], "enrollment": 62, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07912957" }, { "nct_id": "NCT07907029", "title": "Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight or Obesity", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Guangdong Provincial Hospital of Traditional Chinese Medicine", "conditions": [ "Overweight", "Obesity" ], "sites": [ "Zhuhai" ], "enrollment": 50, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07907029" }, { "nct_id": "NCT07911423", "title": "Immunotherapy in Neuroendocrine Carcinoma of the Cervix", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Peking Union Medical College Hospital", "conditions": [ "Cervical Neuroendocrine Carcinoma" ], "sites": [ "Beijing" ], "enrollment": 150, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07911423" }, { "nct_id": "NCT07905950", "title": "Exploratory Study of Short-Course Radiotherapy Followed by Adebrelimab Combined With Chemotherapy for Organ Preservation in Locally Advanced Rectal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Henan Cancer Hospital", "conditions": [ "Locally Advanced Resectable Rectal Cancer" ], "sites": [ "Zhengzhou" ], "enrollment": 155, "start_date": "2026-11-01", "registry_url": "https://clinicaltrials.gov/study/NCT07905950" }, { "nct_id": "NCT07920939", "title": "Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": [ "Type 2 Diabetes" ], "sites": [ "Nanjing", "Shanghai" ], "enrollment": 450, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07920939" }, { "nct_id": "NCT07896629", "title": "Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Xuanwu Hospital, Beijing", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Beijing" ], "enrollment": 60, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07896629" }, { "nct_id": "NCT07865832", "title": "A Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Liangyou Gu", "conditions": [ "Clear Cell Renal Cell Carcinoma" ], "sites": [ "Beijing" ], "enrollment": 6, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07865832" }, { "nct_id": "NCT07891364", "title": "GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "RenJi Hospital", "conditions": [ "Autosomal Dominant Polycystic Kidney" ], "sites": [ "Shanghai" ], "enrollment": 24, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07891364" }, { "nct_id": "NCT07890753", "title": "Biological Aging Following Full-Arch Implant-Supported Fixed Rehabilitation in Edentulous Patients", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Junyu Shi", "conditions": [ "Edentulism", "Biological Aging" ], "sites": [ "Shanghai" ], "enrollment": 60, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07890753" }, { "nct_id": "NCT07923396", "title": "GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Gastric Cancer (GC)" ], "sites": [ "Shanghai" ], "enrollment": 10, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07923396" }, { "nct_id": "NCT07909421", "title": "A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Galderma R&D", "conditions": [ "Cheek Wrinkles", "Midface Contour Deficiencies" ], "sites": [ "Chengdu" ], "enrollment": 326, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07909421" }, { "nct_id": "NCT07840742", "title": "Household Salt Substitution for Hypertension Prevention and Control: The HOME-Salt Trial", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shihezi University", "conditions": [ "Hypertension" ], "sites": [ "Shihezi" ], "enrollment": 800, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07840742" }, { "nct_id": "NCT07909655", "title": "A Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.", "conditions": [ "Idiopathic Pulmonary Fibrosis (IPF)" ], "sites": [ "Changsha", "Shanghai" ], "enrollment": 75, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07909655" }, { "nct_id": "NCT07900867", "title": "This Study Will Evaluate the Effect and Safety of 626 in Patients With CLE", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.", "conditions": [ "Cutaneous Lupus Erythematosus (CLE)" ], "sites": [ "Nanjing", "Beijing" ], "enrollment": 140, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07900867" }, { "nct_id": "NCT07896018", "title": "Clinical Value of EMR3 in Sepsis Diagnosis, Monitoring, and Prognosis: A Multicenter Prospective Observational Study", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Sir Run Run Shaw Hospital", "conditions": [ "Sepsis" ], "sites": [ "Hangzhou" ], "enrollment": 3000, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07896018" }, { "nct_id": "NCT07908654", "title": "A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Guangzhou Patronus Biotech Co., Ltd.", "conditions": [ "Respiratory Syncytial Virus (RSV)", "Respiratory Syncytial Virus (RSV) Infection", "RSV Vaccine" ], "sites": [ "Nanjing" ], "enrollment": 25000, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07908654" }, { "nct_id": "NCT07691762", "title": "A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.", "conditions": [ "Hepatocellular Carcinoma" ], "sites": [ "Nanjing", "Shanghai" ], "enrollment": 690, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07691762" }, { "nct_id": "NCT07906691", "title": "A Study to Assess the Effect of Itraconazole on the Pharmacokinetics of HRS-4642 Following Intravenous Infusion in Healthy Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shanghai Hengrui Pharmaceutical Co., Ltd.", "conditions": [ "Pancreatic Cancer" ], "sites": [ "Changsha" ], "enrollment": 18, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07906691" }, { "nct_id": "NCT07915544", "title": "A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Beijing Gene Key Life Technology Co., Ltd", "conditions": [ "Ankylosing Spondylitis" ], "sites": [ "Beijing" ], "enrollment": 12, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07915544" }, { "nct_id": "NCT07319455", "title": "Heart Voice: Starry Journey - A Digital ACT Intervention for ASD Caregivers", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Harbin Medical University", "conditions": [ "Autism Spectrum Disorder" ], "sites": [ "Daqing" ], "enrollment": 52, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07319455" }, { "nct_id": "NCT07912801", "title": "Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Peking University First Hospital", "conditions": [ "Coronary Artery Disease", "Coronary Artery Bypass Grafting", "Hypoxia-Inducible Factor 1, Alpha Subunit", "Prolyl-Hydroxylase Inhibitors" ], "sites": [ "Beijing" ], "enrollment": 80, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07912801" }, { "nct_id": "NCT07904962", "title": "Different Aerobic-to-Resistance Training Ratios in Adults Aged 50 Years and Older With Prediabetes", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "China Institute of Sport Science", "conditions": [ "Prediabetes" ], "sites": [ "Jining" ], "enrollment": 212, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07904962" }, { "nct_id": "NCT07845565", "title": "FMT Plus SHR-1701 With Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": [ "Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)" ], "sites": [ "Tianjin" ], "enrollment": 60, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07845565" }, { "nct_id": "NCT07905352", "title": "A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of Alzheimer's Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Vigonvita Life Sciences", "conditions": [ "Alzheimer Disease" ], "sites": [ "Beijing" ], "enrollment": 200, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07905352" }, { "nct_id": "NCT07876596", "title": "A Drug-Drug Interaction Study of Rifampicin and Oral HRS-8080", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shandong Suncadia Medicine Co., Ltd.", "conditions": [ "Breast Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 18, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07876596" }, { "nct_id": "NCT07865312", "title": "A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Dermavon Holdings Limited", "conditions": [ "NonSegmental Vitiligo" ], "sites": [ "Hefei", "Beijing", "Chongqing", "Guangzhou", "Jiangmen", "Shenzhen", "Nanning", "Chengde" ], "enrollment": 174, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07865312" }, { "nct_id": "NCT07891338", "title": "Exploratory Study of the Efficacy of HAL-PDT in CIN 3", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tongji Hospital", "conditions": [ "Cervical Intraepithelial Neoplasia Grade 3" ], "sites": [ "Wuhan" ], "enrollment": 260, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07891338" }, { "nct_id": "NCT07860138", "title": "Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid Dynamics", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Fudan University", "conditions": [ "Peripheral Arterial Disease" ], "sites": [ "Shanghai" ], "enrollment": 14, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07860138" }, { "nct_id": "NCT07917104", "title": "Circulating Tumor DNA Methylation-Guided Adjuvant Therapy Decision-Making in Patients With Resectable Colorectal Cancer Liver Metastases After Resection", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fudan University", "conditions": [ "Colorectal Cancer Liver Metastases (CRLM)", "ctDNA" ], "sites": [ "Shanghai" ], "enrollment": 220, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07917104" }, { "nct_id": "NCT07901413", "title": "Evaluation of ICP-B381 in Patients With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Beijing InnoCare Pharma Tech Co., Ltd.", "conditions": [ "Advanced Solid Tumor" ], "sites": [ "Shanghai" ], "enrollment": 348, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07901413" }, { "nct_id": "NCT07914803", "title": "Intranasal Dexmedetomidine-esketamine Combination and Postoperative Cognitive Recovery in Older Patients", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Peking University First Hospital", "conditions": [ "Older Patients", "Noncardiac Surgery", "Dexmedetomidine", "Esketamine" ], "sites": [ "Beijing" ], "enrollment": 732, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07914803" }, { "nct_id": "NCT07698587", "title": "A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Suzhou Biomissile Pharmaceuticals Co., Ltd.", "conditions": [ "Solid Tumor" ], "sites": [ "Hefei" ], "enrollment": 90, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07698587" }, { "nct_id": "NCT07923851", "title": "A Trial Evaluating the Efficacy and Safety of SHR-1139 Injection in Adult Patients With Palmoplantar Pustulosis", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Guangdong Hengrui Pharmaceutical Co., Ltd", "conditions": [ "Palmoplantar Pustulosis of Adults" ], "sites": [ "Guangzhou", "Xi\u2019an" ], "enrollment": 40, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07923851" }, { "nct_id": "NCT07874282", "title": "Phase II Study to Evaluate Telisotuzumab Adizutecan in Combination With RC148(ABBV-1480) as First-Line Treatment for Patients With Non-Squamous Non-Small-Cell Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "RemeGen Co., Ltd.", "conditions": [ "Patients With Locally Advanced or Metastatic Non-Squamous NSCLC Requiring First-Line Treatment and no Driver Gene Alterations Confirmed by Histology or Cytology" ], "sites": [ "Shanghai" ], "enrollment": 200, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07874282" }, { "nct_id": "NCT07888621", "title": "Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and Secondary Central Nervous System Lymphoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": [ "PCNSL (Primary CNS Lymphoma)", "Central Nervous System Lymphoma", "Secondary Central Nervous System Lymphoma (SCNSL)" ], "sites": [ "Nanjing" ], "enrollment": 40, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07888621" }, { "nct_id": "NCT07848945", "title": "Phase I Study of JY1001 Injection", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Jemincare", "conditions": [ "Pain After Surgery" ], "sites": [ "Chengdu" ], "enrollment": 48, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07848945" }, { "nct_id": "NCT07828873", "title": "A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "The First Affiliated Hospital of Zhengzhou University", "conditions": [ "Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma" ], "sites": [ "Zhengzhou" ], "enrollment": 34, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07828873" }, { "nct_id": "NCT07896187", "title": "A Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBS", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Nuwacell Biotechnologies Co., Ltd.", "conditions": [ "PARKINSON DISEASE (Disorder)", "Cell Therapy", "Human Induced Pluripotent Stem Cells", "Deep Brain Stimulation" ], "sites": [ "Beijing" ], "enrollment": 12, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07896187" }, { "nct_id": "NCT07334561", "title": "Transcranial Electrical Stimulation for Comorbid Depression and Chronic Pain", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Mental Health Center", "conditions": [ "Depression Disorder", "Chronic Pain" ], "sites": [ "Shanghai" ], "enrollment": 160, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07334561" }, { "nct_id": "NCT07878871", "title": "Firmonertinib Plus Chemotherapy for Unresectable EGFR PACC-Mutant Stage III Lung Cancer: A Phase II Study", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Hunan Province Tumor Hospital", "conditions": [ "Lung Adenocarcinoma", "Stage III Lung Cancer", "EGFR Positive Non-small Cell Lung Cancer" ], "sites": [ "Changsha" ], "enrollment": 27, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07878871" }, { "nct_id": "NCT07895355", "title": "Phase II Clinical Study of RC148 (ABBV-1480) in Combination With Telisotuzumab Adizutecan (With or Without Chemotherapy) for Unresectable Colorectal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "RemeGen Co., Ltd.", "conditions": [ "Patients With Unresectable Colorectal Cancer Requiring First-Line or Second-Line Therapy" ], "sites": [ "Guangdong" ], "enrollment": 412, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07895355" }, { "nct_id": "NCT07739186", "title": "A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.", "conditions": [ "Non-squamous Non-small Cell Lung Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 166, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07739186" }, { "nct_id": "NCT07855796", "title": "TeriFort 1+ Study: Efficacy and Safety of an Extensively Hydrolyzed Formula in the Management of Cow's Milk Protein Allergy in Young Children: A Prospective, Single-Arm Interventional Study (TeriFort 1+)", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Teyi Yinuo Health Technology Co., Ltd.", "conditions": [ "Cow's Milk Protein Allergy (CMPA)" ], "sites": [ "Shanghai" ], "enrollment": 50, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07855796" }, { "nct_id": "NCT07913061", "title": "A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": [ "Diabetes Mellitus, Type 2" ], "sites": [ "Shenzhen", "Shanghai" ], "enrollment": 680, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07913061" }, { "nct_id": "NCT07463638", "title": "Mindfulness Intervention on Minimally Invasive Vascular Surgery", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Tongji Hospital", "conditions": [ "Anxiety", "Pain", "Varicose Veins of Lower Limb" ], "sites": [ "Wuhan" ], "enrollment": 160, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07463638" }, { "nct_id": "NCT07854977", "title": "Fecal Microbiota Transplantation Combined With NALIRIFOX Plus Serplulimab as First-line Treatment for Advanced or Metastatic Pancreatic Ductal Adenocarcinoma.", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tianjin Medical University Cancer Institute and Hospital", "conditions": [ "Locally Advanced Pancreatic Ductal Adenocarcinoma", "Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)" ], "sites": [ "Tianjin" ], "enrollment": 40, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07854977" }, { "nct_id": "NCT07668895", "title": "Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Peking Union Medical College Hospital", "conditions": [ "Sarcoidosis, Pulmonary" ], "sites": [ "Beijing" ], "enrollment": 126, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07668895" }, { "nct_id": "NCT07861425", "title": "Phase 1 Trial of ACE723, A Dual-Payload Antibody Drug Conjugate, in Patients With Advanced HCC Who Have Failed or Progressed on Standard Systemic Therapy Containing ICIs", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Acepodia Biotech, Inc.", "conditions": [ "Hepatocellular Carcinoma (HCC)", "Hepatocellular Carcinoma Metastatic", "Hepatocellular Carcinoma Non-Resectable" ], "sites": [ "Nanjing", "Shanghai" ], "enrollment": 70, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07861425" }, { "nct_id": "NCT07882043", "title": "Milk Free From A1-Type \u03b2-Casein With Human Milk Oligosaccharides on Gut Health, Immunity, Cognitive Development, and Temperament in Toddlers", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "a2 Milk Company Ltd.", "conditions": [ "Healthy Volunteers" ], "sites": [ "Shenzhen" ], "enrollment": 80, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07882043" }, { "nct_id": "NCT07907653", "title": "Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": [ "Prostate Cancer (Adenocarcinoma)" ], "sites": [ "Guangzhou" ], "enrollment": 37, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07907653" }, { "nct_id": "NCT05901571", "title": "Acupuncture and Escitalopram for Treating Major Depression Clinical Study", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai 7th People's Hospital", "conditions": [ "Depressive Disorder, Major" ], "sites": [ "Shanghai" ], "enrollment": 216, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT05901571" }, { "nct_id": "NCT07889349", "title": "A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Beijing Suncadia Pharmaceuticals Co., Ltd", "conditions": [ "Alzheimer's Disease" ], "sites": [ "Hefei" ], "enrollment": 50, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07889349" }, { "nct_id": "NCT07799129", "title": "Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Eddingpharm (Zhuhai) Co., Ltd.", "conditions": [ "Mixed Dyslipidemia" ], "sites": [ "Harbin", "Zhejiang" ], "enrollment": 144, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07799129" }, { "nct_id": "NCT07923578", "title": "Pharmacokinetics, Safety and Tolerability of Single Sequential and Multiple Intravenous Infusions of Ulinastatin for Injection in Healthy Chinese Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Techpool Bio-Pharma Co., Ltd.", "conditions": [ "Healthy Participants", "Ulinastatin" ], "sites": [ "Hefei" ], "enrollment": 40, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07923578" }, { "nct_id": "NCT07894315", "title": "EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "First Affiliated Hospital of Fujian Medical University", "conditions": [ "Ischemic Stroke", "Post-stroke Dysphagia", "Swallowing Disorders" ], "sites": [ "Fuzhou", "Zhangzhou", "Zhengzhou", "Xi'an", "Beijing" ], "enrollment": 60, "start_date": "2026-11", "registry_url": "https://clinicaltrials.gov/study/NCT07894315" }, { "nct_id": "NCT07866391", "title": "Vitamin D Status and Its Influencing Factors in Zhejiang Province: A Multicenter Cross-Sectional Study", "status": "ENROLLING_BY_INVITATION", "phase": "Observational", "lead_sponsor": "First Affiliated Hospital of Zhejiang University", "conditions": [ "Vitamin D Deficiency" ], "sites": [ "Hangzhou", "Lishui" ], "enrollment": 10000, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07866391" }, { "nct_id": "NCT07462455", "title": "Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic(PK/PD) Profile of ACT500 in Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD)", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Xiamen Amoytop Biotech Co., Ltd.", "conditions": [ "Metabolic Dysfunction-associated Steatohepatitis" ], "sites": [ "Beijing", "Shanghai", "Xi'an", "Xiamen" ], "enrollment": 24, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07462455" }, { "nct_id": "NCT07836270", "title": "A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Hangzhou Sciwind Biosciences Co., Ltd.", "conditions": [ "Adolescents With Obesity", "Adolescents With Overweight & Weight-related Comorbidities" ], "sites": [ "Hangzhou" ], "enrollment": 192, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07836270" }, { "nct_id": "NCT07796256", "title": "Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Suzhou Sanegene Bio Inc.", "conditions": [ "PNH - Paroxysmal Nocturnal Hemoglobinuria" ], "sites": [ "Tianjin", "Hangzhou" ], "enrollment": 24, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07796256" }, { "nct_id": "NCT07875374", "title": "40 Hz Gamma Auditory Stimulation for Delirium Prevention in Critically Ill ICU Patients", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking Union Medical College Hospital", "conditions": [ "Delirium" ], "sites": [ "Beijing" ], "enrollment": 142, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07875374" }, { "nct_id": "NCT07755956", "title": "Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.", "conditions": [ "Endometriosis" ], "sites": [ "Changsha", "Suzhou" ], "enrollment": 20, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07755956" }, { "nct_id": "NCT07854639", "title": "A Prospective Clinical Study of Zeprumetosta in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Peking University First Hospital", "conditions": [ "Cutaneous T-Cell Lymphoma/Mycosis Fungoides/S\u00e9zary Syndrome" ], "sites": [ "Beijing" ], "enrollment": 33, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07854639" }, { "nct_id": "NCT07795658", "title": "China CRSwNP Registry Study", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Beijing Tongren Hospital", "conditions": [ "Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)" ], "sites": [ "Beijing" ], "enrollment": 1000, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07795658" }, { "nct_id": "NCT07222553", "title": "Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Amgen", "conditions": [ "Immunoglobulin G4-related Disease" ], "sites": [ "Beijing", "Changsha" ], "enrollment": 15, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07222553" }, { "nct_id": "NCT07854665", "title": "Transcutaneous Auricular Vagus Nerve Stimulation for Chronic Tic Disorders/Tourette's Syndrome in Children and Adolescents", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The First Affiliated Hospital of Zhejiang Chinese Medical University", "conditions": [ "Tourette Syndrome", "Chronic Tic Disorder" ], "sites": [ "Hangzhou" ], "enrollment": 124, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07854665" }, { "nct_id": "NCT07870772", "title": "Lenvatinib Plus Bevacizumab and PD-1 Inhibition Versus Bevacizumab Plus PD-1 Inhibition After Progression on Bevacizumab Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Prospective, Randomized, Two-Cohort, Phase II Study", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Hepatocellulcar Carcinoma" ], "sites": [ "Guangzhou" ], "enrollment": 100, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07870772" }, { "nct_id": "NCT07875881", "title": "A Phase 3 Study of Deutenzalutamide in Patients With High-Risk BCR Prostate Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Hinova Pharmaceuticals Inc.", "conditions": [ "High Risk Biochemical Recurrence (BCR)", "Deutenzalutamide Soft Capsules" ], "sites": [ "Beijing", "Shanghai", "Chengdu" ], "enrollment": 1044, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07875881" }, { "nct_id": "NCT07834359", "title": "A Study of HS-20197 in Participants With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Hansoh BioMedical R&D Company", "conditions": [ "Solid Tumors" ], "sites": [ "Guangzhou" ], "enrollment": 595, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07834359" }, { "nct_id": "NCT07819630", "title": "Electroencephalogram Changes Induced by Transcutaneous Electrical Acupoint Stimulation", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Chao Yang Hospital", "conditions": [ "Postoperative Pain" ], "sites": [ "Beijing" ], "enrollment": 90, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07819630" }, { "nct_id": "NCT07258147", "title": "Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Sichuan University", "conditions": [ "Lung Cancer (SCLC)" ], "sites": [ "Chengdu" ], "enrollment": 30, "start_date": "2026-10-31", "registry_url": "https://clinicaltrials.gov/study/NCT07258147" }, { "nct_id": "NCT07768111", "title": "Clinical Study on Drug Interactions of Flonoltinib Maleate Tablets", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Chengdu Zenitar Biomedical Technology Co., Ltd", "conditions": [ "Drug Interaction Research" ], "sites": [ "Hefei" ], "enrollment": 40, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07768111" }, { "nct_id": "NCT07893340", "title": "First-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for Unresectable Advanced Malignant Peritoneal Mesothelioma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fudan University", "conditions": [ "Peritoneal Mesothelioma", "First-line Therapy" ], "sites": [ "Shanghai" ], "enrollment": 19, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07893340" }, { "nct_id": "NCT07897188", "title": "ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu Aosaikang Pharmaceutical Co., Ltd.", "conditions": [ "EGFR Activating Mutation", "Non-Squamous Non-Small Cell Lung Cancer (NSCLC)", "MET Positive" ], "sites": [ "Shanghai" ], "enrollment": 425, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07897188" }, { "nct_id": "NCT07881094", "title": "China Healthy Aging and Fitness Longitudinal Study", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "China Institute of Sport Science", "conditions": [ "Physical Fitness", "Aging" ], "sites": [ "Beijing" ], "enrollment": 8960, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07881094" }, { "nct_id": "NCT07589400", "title": "Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Xiamen Amoytop Biotech Co., Ltd.", "conditions": [ "Metabolic Dysfunction-associated Steatotic Liver Disease", "Chronic Hepatitis b" ], "sites": [ "Beijing", "Shanghai", "\u00dcr\u00fcmqi", "Xiamen" ], "enrollment": 24, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07589400" }, { "nct_id": "NCT07876609", "title": "A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1203 in Advanced Solid Tumors.", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shandong Boan Biotechnology Co., Ltd", "conditions": [ "Solid Tumors" ], "sites": [ "Beijing" ], "enrollment": 120, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07876609" }, { "nct_id": "NCT07767396", "title": "Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shaanxi Normal University", "conditions": [ "Post-traumatic Stress Disorder (PTSD)", "Intrusive Memories of Traumatic Event(s)" ], "sites": [ "Xi'an" ], "enrollment": 117, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07767396" }, { "nct_id": "NCT07868172", "title": "GST101 in Participants With RAS-Mutant Advanced Solid Tumors", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Genuine Seed Therapeutics (Zhuhai) Co., Ltd.", "conditions": [ "RAS-mutant Advanced Solid Tumors" ], "sites": [ "Harbin", "Wuhan", "Jinan", "Shanghai", "Chengdu", "Hangzhou" ], "enrollment": 172, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07868172" }, { "nct_id": "NCT07890649", "title": "A Study of hBMMSC Injection in Patients With aPAP", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.", "conditions": [ "Autoimmune Pulmonary Alveolar Proteinosis" ], "sites": [ "Guangzhou" ], "enrollment": 70, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07890649" }, { "nct_id": "NCT07840820", "title": "Phase II/III Study of FXS5626 in Participants With Non-segmental Vitiligo", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": [ "Non-segmental Vitiligo" ], "sites": [ "Shanghai" ], "enrollment": 480, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07840820" }, { "nct_id": "NCT07863167", "title": "An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.", "conditions": [ "Non-small Cell Lung Cancer" ], "sites": [ "Guangzhou" ], "enrollment": 660, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07863167" }, { "nct_id": "NCT07672496", "title": "Ulinastatin on Systemic Immune-Inflammation in Patients With Complicated Intra-Abdominal Infection", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Fujian Medical University Union Hospital", "conditions": [ "Complicated Intra-abdominal Infection (cIAI)", "Systemic Inflammatory Response", "Sepsis", "Immune Dysfunction" ], "sites": [ "Fuzhou" ], "enrollment": 165, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07672496" }, { "nct_id": "NCT07800507", "title": "Trop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Yunnan Cancer Hospital", "conditions": [ "NMIBC" ], "sites": [ "Kunming" ], "enrollment": 30, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07800507" }, { "nct_id": "NCT07923357", "title": "A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shenzhen Salubris Pharmaceuticals Co., Ltd.", "conditions": [ "Type 2 Diabetes Mellitus (T2DM)", "Type 2 Diabetes", "T2DM" ], "sites": [ "Beijing" ], "enrollment": 364, "start_date": "2026-10-30", "registry_url": "https://clinicaltrials.gov/study/NCT07923357" }, { "nct_id": "NCT07816237", "title": "A Multicenter, Randomized, Open-Label, Positive Controlled Phase III Study to Evaluate the Efficacy and Safety of VSA012 Injection in Participants With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Bisirna Therapeutics (Suzhou) Co., Ltd.", "conditions": [ "Paroxysmal Nocturnal Hemoglobinuria, PNH" ], "sites": [ "Beijing", "Jilin City", "Quanzhou", "Guangzhou", "Nanning", "Harbin", "Zhengzhou", "Wuhan" ], "enrollment": 70, "start_date": "2026-10-29", "registry_url": "https://clinicaltrials.gov/study/NCT07816237" }, { "nct_id": "NCT07917962", "title": "Foraminal Imaging and Symptoms in Single-Level Degenerative Lumbar Stenosis", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine", "conditions": [ "Degenerative Lumbar Spinal Stenosis", "Lumbar Foraminal Stenosis" ], "sites": [ "Guangzhou" ], "enrollment": 120, "start_date": "2026-10-29", "registry_url": "https://clinicaltrials.gov/study/NCT07917962" }, { "nct_id": "NCT07797244", "title": "A Single-Arm, Phase II Study of Retlirafusp Alfa in Combination With XELOX and Bevacizumab for the First-Line Treatment of Advanced RAS-Mutated Colorectal Cancer With Liver Metastases (CRLM)", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Dai, Guanghai", "conditions": [ "Advanced RAS-Mutated Colorectal Cancer With Liver Metastases (CRLM)" ], "sites": [ "Beijing" ], "enrollment": 46, "start_date": "2026-10-29", "registry_url": "https://clinicaltrials.gov/study/NCT07797244" }, { "nct_id": "NCT07914842", "title": "Cortical Surface Functional Changes After Lever Positioning Manipulation for Lumbar Disc Herniation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Third Affiliated hospital of Zhejiang Chinese Medical University", "conditions": [ "Lumbar Disc Herniation" ], "sites": [ "Hangzhou" ], "enrollment": 60, "start_date": "2026-10-29", "registry_url": "https://clinicaltrials.gov/study/NCT07914842" }, { "nct_id": "NCT07748637", "title": "A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Daishi Tian", "conditions": [ "Multiple Sclerosis (MS)" ], "sites": [ "Wuhan" ], "enrollment": 12, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07748637" }, { "nct_id": "NCT07904949", "title": "Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Recovery Quality in Patients Undergoing Anterior Cruciate Ligament Reconstruction", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University Third Hospital", "conditions": [ "Anterior Cruciate Ligament Injuries", "Recovery Quality", "Auricular Vagus Nerve Stimulation" ], "sites": [ "Beijing" ], "enrollment": 144, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07904949" }, { "nct_id": "NCT07872254", "title": "A Feasibility Study of a Digitally-enabled Psychological Intervention for Demoralization in Advanced Cancer Patients", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The Hong Kong Polytechnic University", "conditions": [ "Advanced Cancer", "Demoralization", "Psychological Intervention" ], "sites": [ "Shenzhen" ], "enrollment": 30, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07872254" }, { "nct_id": "NCT07707895", "title": "DAREON\u00ae-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Boehringer Ingelheim", "conditions": [ "Small Cell Lung Cancer", "Large Cell Neuroendocrine Lung Carcinoma", "Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology", "Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology" ], "sites": [ "Nanning", "Shanghai" ], "enrollment": 60, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07707895" }, { "nct_id": "NCT07884864", "title": "A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Ausper Biopharma Co., Ltd.", "conditions": [ "Chronic Hepatitis B Virus" ], "sites": [ "Shanghai" ], "enrollment": 110, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07884864" }, { "nct_id": "NCT07842497", "title": "A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": [ "Acute Gouty Arthritis" ], "sites": [ "Jing\u2019an" ], "enrollment": 132, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07842497" }, { "nct_id": "NCT07920744", "title": "The Value of Spleen Thickness and Spleen Diameter for Gastroesophageal Varices Diagnosis in Compensated Cirrhosis", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Fifth Affiliated Hospital, Sun Yat-Sen University", "conditions": [ "Liver Cirrhosis", "Gastroesophageal Varices" ], "sites": [ "Zhuhai" ], "enrollment": 364, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07920744" }, { "nct_id": "NCT07874633", "title": "A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Pfizer", "conditions": [ "Obesity", "Overweight" ], "sites": [ "Hefei", "Beijing", "Huizhou", "Zhengzhou", "Nanjing", "Nanchang" ], "enrollment": 432, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07874633" }, { "nct_id": "NCT07791251", "title": "Efficacy and Safety of Inhaled Peramivir Solution for the Treatment of Adults With Uncomplicated Influenza", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Capital Medical University", "conditions": [ "Influenza Infection" ], "sites": [ "Beijing" ], "enrollment": 600, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07791251" }, { "nct_id": "NCT07844512", "title": "Safety and Analgesic Efficacy of the Biased \u03bc-Opioid Receptor Agonist Tegileridine for Post-Operative Analgesia in Patients Undergoing Bariatric Surgery", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "The First Hospital of Jilin University", "conditions": [ "Pain Management", "Overweight , Obesity", "Respiration; Sleep Disorder" ], "sites": [ "Changchun" ], "enrollment": 148, "start_date": "2026-10-28", "registry_url": "https://clinicaltrials.gov/study/NCT07844512" }, { "nct_id": "NCT07613359", "title": "A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Takeda", "conditions": [ "Antibody-Mediated Rejection (AMR)" ], "sites": [ "Beijing", "Guangdong", "Nanning", "Wuhan", "Xi'an", "Jinan", "Chengdu", "Hangzhou" ], "enrollment": 36, "start_date": "2026-10-27", "registry_url": "https://clinicaltrials.gov/study/NCT07613359" }, { "nct_id": "NCT07816341", "title": "F182112 in Relapsed/Refractory Autoimmune Hemolytic Anemia", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": [ "Autoimmune Hemolytic Anemia" ], "sites": [ "Tianjin" ], "enrollment": 12, "start_date": "2026-10-27", "registry_url": "https://clinicaltrials.gov/study/NCT07816341" }, { "nct_id": "NCT07856797", "title": "A Study to Confirm Safety and Effectiveness of RADIESSE\u00ae Injectable Implant for the Correction of Moderate to Severe Nasolabial Folds", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Merz North America, Inc.", "conditions": [ "Nasolabial Folds" ], "sites": [ "Beijing", "Changde", "Chengdu", "Gaozhou", "Hangzhou", "Nanjing", "Xianyang", "Yibin" ], "enrollment": 163, "start_date": "2026-10-27", "registry_url": "https://clinicaltrials.gov/study/NCT07856797" }, { "nct_id": "NCT07802821", "title": "A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-na\u00efve Extensive-Stage Small Cell Lung Cancer", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Qilu Pharmaceutical Co., Ltd.", "conditions": [ "Extensive-stage Small Cell Lung Cancer" ], "sites": [ "Shanghai" ], "enrollment": 556, "start_date": "2026-10-27", "registry_url": "https://clinicaltrials.gov/study/NCT07802821" }, { "nct_id": "NCT07923812", "title": "Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Fudan University", "conditions": [ "Alzheimer's Disease (AD)" ], "sites": [ "Shanghai" ], "enrollment": 3000, "start_date": "2026-10-26", "registry_url": "https://clinicaltrials.gov/study/NCT07923812" }, { "nct_id": "NCT07861100", "title": "A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Novo Nordisk A/S", "conditions": [ "Cardiovascular Risk", "Obesity" ], "sites": [ "Beijing", "Chongqing", "Guangzhou", "Shijiazhuang", "Luoyang", "Changsha", "Changzhou", "Nanjing" ], "enrollment": 8500, "start_date": "2026-10-26", "registry_url": "https://clinicaltrials.gov/study/NCT07861100" }, { "nct_id": "NCT07892846", "title": "The Intervention Effect of Exercise on Lumbar Multifidus Muscle Injuries", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Chinese PLA General Hospital", "conditions": [ "Chronic Non-specific Low Back Pain", "Lumbar Multifidus Muscle Injury" ], "sites": [ "Beijing" ], "enrollment": 40, "start_date": "2026-10-26", "registry_url": "https://clinicaltrials.gov/study/NCT07892846" }, { "nct_id": "NCT07701343", "title": "tACS for Working Memory in Schizophrenia", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Central South University", "conditions": [ "Schizophrenia", "Working Memory" ], "sites": [ "Changsha" ], "enrollment": 30, "start_date": "2026-10-26", "registry_url": "https://clinicaltrials.gov/study/NCT07701343" }, { "nct_id": "NCT07609654", "title": "Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Second Affiliated Hospital, Zhejiang University, School of Medicine", "conditions": [ "Intracerebral Hemorrhage", "Atrial Fibrillation (AF)", "Ischemia Stroke" ], "sites": [ "Hangzhou" ], "enrollment": 852, "start_date": "2026-10-26", "registry_url": "https://clinicaltrials.gov/study/NCT07609654" }, { "nct_id": "NCT07644650", "title": "Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Mabsoft Therapeutics (Shanghai) Co., Ltd.", "conditions": [ "Neoplams" ], "sites": [ "Shanghai" ], "enrollment": 420, "start_date": "2026-10-26", "registry_url": "https://clinicaltrials.gov/study/NCT07644650" }, { "nct_id": "NCT07902596", "title": "Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "The First Affiliated Hospital with Nanjing Medical University", "conditions": [ "Gastric Adenocarcinoma", "Esophagogastric Junction Adenocarcinoma" ], "sites": [ "Shijiazhuang", "Lianyungang", "Nanjing", "Suzhou", "Qingdao", "Shanghai" ], "enrollment": 2000, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07902596" }, { "nct_id": "NCT07872579", "title": "Mass Balance Study of [\u00b9\u2074C]FXS4640 in Healthy Adult Males", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.", "conditions": [ "Healthy Subjects" ], "sites": [ "Wuxi" ], "enrollment": 6, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07872579" }, { "nct_id": "NCT07903623", "title": "QLS4131 Plus Isatuximab in Newly Diagnosed Primary Plasma Cell Leukemia", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": [ "Primary Plasma Cell Leukemia" ], "sites": [ "Tianjin" ], "enrollment": 15, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07903623" }, { "nct_id": "NCT07897305", "title": "Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Anzhen Hospital", "conditions": [ "Atrial Fibrillation (AF)", "Ablation Treatment", "Obesity & Overweight", "Mazdutide" ], "sites": [ "Beijing" ], "enrollment": 700, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07897305" }, { "nct_id": "NCT07909200", "title": "Temporal Interference Transcranial Alternating Current Stimulation Targeting the BNST or Amygdala for Generalized Anxiety Disorder", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Central South University", "conditions": [ "Generalized Anxiety Disorder (GAD)" ], "sites": [ "Fuzhou", "Changsha", "Yangzhou" ], "enrollment": 75, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07909200" }, { "nct_id": "NCT07893249", "title": "Individual Variability in Energy Compensation After a 12-Week Supervised Exercise Intervention", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences", "conditions": [ "Physical Inactivity", "Overweight", "Obesity" ], "sites": [ "Shenzhen" ], "enrollment": 150, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07893249" }, { "nct_id": "NCT07741253", "title": "PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "China National Center for Cardiovascular Diseases", "conditions": [ "Atrial Functional", "Mitral Regurgitation (MR)" ], "sites": [ "Beijing" ], "enrollment": 182, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07741253" }, { "nct_id": "NCT07906327", "title": "Corneal Biomechanics and Stromal Tissue Characteristics in Patients Undergoing SMILE", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Tongji University", "conditions": [ "Myopia" ], "sites": [ "Shanghai" ], "enrollment": 200, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07906327" }, { "nct_id": "NCT07350863", "title": "U69-CART-Cells For R/R T-ALL", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "The First Affiliated Hospital of Soochow University", "conditions": [ "Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma" ], "sites": [ "Suzhou" ], "enrollment": 12, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07350863" }, { "nct_id": "NCT07877103", "title": "Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "The First Affiliated Hospital of Guangzhou Medical University", "conditions": [ "End-Stage Renal Disease" ], "sites": [ "Guangzhou" ], "enrollment": 100, "start_date": "2026-10-25", "registry_url": "https://clinicaltrials.gov/study/NCT07877103" }, { "nct_id": "NCT07923058", "title": "Clinical Trial of SEEG for Drug-resistant Epilepsy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing Pins Medical Co., Ltd", "conditions": [ "Drug-Resistant Epilepsy" ], "sites": [ "Beijing", "Chongqing", "Fuzhou", "Guangzhou", "Harbin", "Wuhan", "Changsha", "Jinan" ], "enrollment": 99, "start_date": "2026-10-23", "registry_url": "https://clinicaltrials.gov/study/NCT07923058" }, { "nct_id": "NCT07889245", "title": "A Phase II Study of FXR0906 in Patients With Severe Hypertriglyceridemia or Hypertriglyceridemia With ASCVD.", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fosun Pharmaceutical Industrial Development (Shenzhen) Co., Ltd.", "conditions": [ "sHTG", "HTG With ASCVD (Diagnosed or at Increased Risk)" ], "sites": [ "Beijing" ], "enrollment": 192, "start_date": "2026-10-23", "registry_url": "https://clinicaltrials.gov/study/NCT07889245" }, { "nct_id": "NCT07754123", "title": "Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Jiangsu Hansoh Pharmaceutical Co., Ltd.", "conditions": [ "Advanced or Metastatic NSCLC" ], "sites": [ "Guangzhou" ], "enrollment": 206, "start_date": "2026-10-23", "registry_url": "https://clinicaltrials.gov/study/NCT07754123" }, { "nct_id": "NCT07663630", "title": "A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Pfizer", "conditions": [ "Non-small Cell Lung Cancer (NSCLC)", "Cachexia" ], "sites": [ "Shenzhen" ], "enrollment": 80, "start_date": "2026-10-23", "registry_url": "https://clinicaltrials.gov/study/NCT07663630" }, { "nct_id": "NCT07888569", "title": "Assessing the Effect of a Proton Pump Inhibitor on the Pharmacokinetics of DZD8586 in Healthy Participants (TAI-SHAN21)", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Dizal Pharmaceuticals", "conditions": [ "Healthy" ], "sites": [ "Beijing" ], "enrollment": 26, "start_date": "2026-10-23", "registry_url": "https://clinicaltrials.gov/study/NCT07888569" }, { "nct_id": "NCT07843303", "title": "Trastuzumab Rezetecan Plus Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Peking University Cancer Hospital & Institute", "conditions": [ "Ovarian Cancer", "Fallopian Tube Cancers", "Primary Peritoneal Cancer" ], "sites": [ "Beijing" ], "enrollment": 53, "start_date": "2026-10-22", "registry_url": "https://clinicaltrials.gov/study/NCT07843303" }, { "nct_id": "NCT07876557", "title": "A Clinical Study to Evaluate the Efficacy and Safety of JS212 Monotherapy or Combination Therapy in Recurrent or Metastatic Triple-negative Breast Cancer(TNBC)", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Junshi Bioscience Co., Ltd.", "conditions": [ "Triple-negative Breast Cancer" ], "sites": [ "Beijing", "Fuzhou", "Lanzhou", "Guangzhou", "Guiyang", "Baoding", "Harbin", "Zhengzhou" ], "enrollment": 184, "start_date": "2026-10-22", "registry_url": "https://clinicaltrials.gov/study/NCT07876557" }, { "nct_id": "NCT07885436", "title": "68Ga-XHER2 PET/CT for HER2 Assessment", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "The First Affiliated Hospital of Xiamen University", "conditions": [ "Solid Tumor (Excluding CNS)", "HER2", "PET / CT" ], "sites": [ "Xiamen" ], "enrollment": 80, "start_date": "2026-10-22", "registry_url": "https://clinicaltrials.gov/study/NCT07885436" }, { "nct_id": "NCT07822711", "title": "Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University Third Hospital", "conditions": [ "Spinal Muscular Atrophy (SMA)" ], "sites": [ "Beijing" ], "enrollment": 13, "start_date": "2026-10-22", "registry_url": "https://clinicaltrials.gov/study/NCT07822711" }, { "nct_id": "NCT07882628", "title": "Diagnostic Performance of an AI-Based Multi-Omics Model for Early Lung Cancer", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Beijing Chao Yang Hospital", "conditions": [ "Pulmonary Nodules", "Early Detection of Cancer", "Lung Neoplasms" ], "sites": [ "Beijing", "Changsha" ], "enrollment": 1050, "start_date": "2026-10-21", "registry_url": "https://clinicaltrials.gov/study/NCT07882628" }, { "nct_id": "NCT07885423", "title": "68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "The First Affiliated Hospital of Xiamen University", "conditions": [ "Prostate Cancer (Diagnosis)", "ACP3", "PET / CT" ], "sites": [ "Xiamen" ], "enrollment": 25, "start_date": "2026-10-21", "registry_url": "https://clinicaltrials.gov/study/NCT07885423" }, { "nct_id": "NCT07858916", "title": "A Phase 2b Study to Evaluate the Efficacy, Safety, and PK Profiles of TNP-2092 Administered Via IA Injection in PJI Participants", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "TenNor Therapeutics (Zhongshan) Limited", "conditions": [ "Prosthetic Joint Infection (PJI)" ], "sites": [ "\u00dcr\u00fcmqi" ], "enrollment": 40, "start_date": "2026-10-21", "registry_url": "https://clinicaltrials.gov/study/NCT07858916" }, { "nct_id": "NCT07893847", "title": "Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Capital Medical University", "conditions": [ "Influenza, Human" ], "sites": [ "Beijing" ], "enrollment": 570, "start_date": "2026-10-21", "registry_url": "https://clinicaltrials.gov/study/NCT07893847" }, { "nct_id": "NCT07879547", "title": "Safety and Diagnostic Efficacy of 177Lu-AF03 in Patients With Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Yong He", "conditions": [ "Malignant Solid Tumors", "Neoplasms" ], "sites": [ "Wuhan" ], "enrollment": 8, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07879547" }, { "nct_id": "NCT07827521", "title": "Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "First Affiliated Hospital of Wenzhou Medical University", "conditions": [ "Chronic Limb-Threatening Ischemia", "Diabetic Foot Ulcer", "Infrapopliteal Arterial Occlusive Disease" ], "sites": [ "Hangzhou", "Taizhou", "Wenzhou" ], "enrollment": 180, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07827521" }, { "nct_id": "NCT07830199", "title": "A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.", "conditions": [ "Solid Tumor" ], "sites": [ "Shenyang", "Tianjin" ], "enrollment": 208, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07830199" }, { "nct_id": "NCT07880353", "title": "Real-World Outcomes of Sevabertinib in HER2-Mutant Advanced NSCLC: A Bidirectional Cohort Study", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Ruijin Hospital", "conditions": [ "HER2-mutant Advanced Non-Small Cell Lung Cancer" ], "sites": [ "Qionghai" ], "enrollment": 16, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07880353" }, { "nct_id": "NCT07873346", "title": "Study on Changes in Gut Microbiota, Inflammatory Factors, and Bowel Habits Following Oral Administration of Recombinant B-subunit/Whole Cell Cholera Vaccine in a Community Population", "status": "NOT_YET_RECRUITING", "phase": "Phase 4", "lead_sponsor": "Zhejiang Provincial Center for Disease Control and Prevention", "conditions": [ "Bowel Habits", "Gut Microbiomes", "Inflamatory Markers" ], "sites": [ "Ningbo" ], "enrollment": 200, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07873346" }, { "nct_id": "NCT07878221", "title": "A Phase II Study of Ipilimumab N01 Plus Sintilimab for MSI-H or dMMR Gastric and Gastroesophageal Junction Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fudan University", "conditions": [ "Gastric / Gastroesophageal Junction Adenocarcinoma" ], "sites": [ "Shanghai" ], "enrollment": 36, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07878221" }, { "nct_id": "NCT07829575", "title": "Amygdala-Targeted Transcranial Temporal Interference Stimulation for Major Depressive Disorder: A Randomized Sham-Controlled Trial of Clinical Efficacy and Neurobiological Mechanisms", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University", "conditions": [ "Major Depressive Disorder (MDD" ], "sites": [ "Shanghai" ], "enrollment": 60, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07829575" }, { "nct_id": "NCT07880548", "title": "Remimazolam vs Propofol for Long-Term Sedation in Mechanically Ventilated ICU Patients", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Sun Yat-sen University", "conditions": [ "Long-term Sedation for Mechanical Ventilation", "Critically Ill Intensive Care Unit Patients" ], "sites": [ "Dongguan", "Guangzhou", "Shenzhen", "Nanning", "Luoyang", "Zhengzhou", "Wuhan", "Nantong" ], "enrollment": 274, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07880548" }, { "nct_id": "NCT07779538", "title": "Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.", "conditions": [ "Ovarian Cancer" ], "sites": [ "Beijing", "Zhejiang", "Yunnan" ], "enrollment": 420, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07779538" }, { "nct_id": "NCT07889635", "title": "The Effects of an Empower_ICE-Fit Program in PLwD Living at Home", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "The University of Hong Kong", "conditions": [ "Dementia" ], "sites": [ "Binzhou", "Jinan" ], "enrollment": 304, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07889635" }, { "nct_id": "NCT07915726", "title": "Endoscopic Papillectomy Versus Surgery for Ampullary Tumors: A Prospective Multicenter Cohort Study", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Qilu Hospital of Shandong University", "conditions": [ "Ampullary Neoplasm", "Ampullary Adenoma" ], "sites": [ "Jinan" ], "enrollment": 306, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07915726" }, { "nct_id": "NCT07471698", "title": "hiPSC-CMs-loaded Chitosan Patch to Treat Severe Chronic Ischemic Heart Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "HELP Therapeutics Co., Ltd.", "conditions": [ "Ischemic Heart Failure", "CABG-patients" ], "sites": [ "Changsha" ], "enrollment": 16, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07471698" }, { "nct_id": "NCT07890636", "title": "Adebrelimab Plus Famitinib as Adjuvant Therapy in Non-pCR NSCLC", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Lung Neoplasm Malignant" ], "sites": [ "Shanghai" ], "enrollment": 64, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07890636" }, { "nct_id": "NCT07902999", "title": "HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient Endometrial Cancer", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.", "conditions": [ "First-line pMMR Endometrial Cancer" ], "sites": [ "Guangzhou", "Shenyang" ], "enrollment": 333, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07902999" }, { "nct_id": "NCT07890701", "title": "A Single-Arm,Multicenter Phase, Phase II Clinical Trial of Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents", "status": "ENROLLING_BY_INVITATION", "phase": "Phase 1/2", "lead_sponsor": "Second Affiliated Hospital of Wenzhou Medical University", "conditions": [ "Histiocytosis,Langerhans-Cell" ], "sites": [ "Wenzhou" ], "enrollment": 2, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07890701" }, { "nct_id": "NCT07840729", "title": "Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "Shanghai JMT-Bio Inc.", "conditions": [ "Valid MeSH Conditiongs" ], "sites": [ "Beijing" ], "enrollment": 90, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07840729" }, { "nct_id": "NCT07891715", "title": "Biliary Plus Pancreatic Stent vs Pancreatic Stent Alone After Endoscopic Papillectomy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Qilu Hospital of Shandong University", "conditions": [ "Post-Procedural Complications" ], "sites": [ "Jinan" ], "enrollment": 190, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07891715" }, { "nct_id": "NCT07883070", "title": "Study of Anxiety and Depression in Patients With Hematologic Malignancies", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "The First Affiliated Hospital of Xiamen University", "conditions": [ "Hematologic Disease" ], "sites": [ "Xiamen" ], "enrollment": 100, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07883070" }, { "nct_id": "NCT07888699", "title": "WST03 Capsule Combined With Metronidazole for Bacterial Vaginosis", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "SPH Sine Pharmaceutical Laboratories Co., Ltd.", "conditions": [ "Bacterial Vaginosis (BV)" ], "sites": [ "Beijing", "Chongqing", "Shenzhen", "Liuzhou", "Xinxiang", "Shiyan", "Zhuzhou", "Changchun" ], "enrollment": 150, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07888699" }, { "nct_id": "NCT07561073", "title": "Stomach-Partitioning Versus Conventional Gastrojejunostomy for Malignant Gastric Outlet Obstruction: A Multicenter Randomized Controlled Trial", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Guangxi Medical University", "conditions": [ "Gastric Cancer", "Gastric Outlet Obstruction" ], "sites": [ "Nanning", "Wuzhou" ], "enrollment": 80, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07561073" }, { "nct_id": "NCT07875803", "title": "Comparison of the Pharmacokinetic (PK) and Pharmacodynamic (PD) Biosimilarity of Insulin Aspart 30 Injections After Single-Dose Subcutaneous Administration to Healthy Volunteers", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Zhuhai United Laboratories Co., Ltd.", "conditions": [ "Pharmacokinetics and Pharmacodynamics" ], "sites": [ "Xingtai" ], "enrollment": 52, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07875803" }, { "nct_id": "NCT07879469", "title": "Antibody-Drug Conjugate Plus Immunotherapy Versus Immunotherapy Plus Chemotherapy for Extensive Transurethrally Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Tianjin Medical University Second Hospital", "conditions": [ "Bladder (Urothelial, Transitional Cell) Cancer", "Antibody-drug Conjugates", "Immunotherapy", "Chemotherapy" ], "sites": [ "Tianjin", "Xingtai" ], "enrollment": 150, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07879469" }, { "nct_id": "NCT07809178", "title": "China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm", "status": "ACTIVE_NOT_RECRUITING", "phase": "Observational", "lead_sponsor": "Cheng sen", "conditions": [ "Unruptured Intracranial Aneurysms", "Pituitary Neuroendocrine Tumor", "Craniopharyngioma", "Meningioma" ], "sites": [ "Beijing" ], "enrollment": 608, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07809178" }, { "nct_id": "NCT07844187", "title": "TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.", "conditions": [ "Colorectal Neoplasms" ], "sites": [ "Beijing", "Lanzhou", "Foshan", "Nanning", "Harbin", "Zhengzhou", "Wuhan", "Changsha" ], "enrollment": 64, "start_date": "2026-10-20", "registry_url": "https://clinicaltrials.gov/study/NCT07844187" }, { "nct_id": "NCT07890922", "title": "AI-Assisted Systemic Health Risk Assessment in General Ophthalmology", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": [ "Systemic Health Risk" ], "sites": [ "Guangzhou" ], "enrollment": 2000, "start_date": "2026-10-19", "registry_url": "https://clinicaltrials.gov/study/NCT07890922" }, { "nct_id": "NCT07876440", "title": "A Clinical Study of HH-1270 in Healthy Chinese Subjects", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Huahui Health", "conditions": [ "Chronic HDV Infection" ], "sites": [ "Beijing" ], "enrollment": 88, "start_date": "2026-10-19", "registry_url": "https://clinicaltrials.gov/study/NCT07876440" }, { "nct_id": "NCT07877194", "title": "A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Summit Therapeutics", "conditions": [ "Renal Cell Carcinoma, Clear Cell" ], "sites": [ "Beijing" ], "enrollment": 100, "start_date": "2026-10-19", "registry_url": "https://clinicaltrials.gov/study/NCT07877194" }, { "nct_id": "NCT07919119", "title": "Risk Stratification Value of Deep NGS-MRD Detection in Acute Myeloid Leukemia Patients After Allo-HSCT", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": [ "Measurable Residual Disease", "Acute Myeloid Leukemia" ], "sites": [ "Tianjin" ], "enrollment": 169, "start_date": "2026-10-19", "registry_url": "https://clinicaltrials.gov/study/NCT07919119" }, { "nct_id": "NCT07847905", "title": "A Phase I/II of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "LaNova Medicines Limited", "conditions": [ "Advanced Solid Tumor Cancer" ], "sites": [ "Beijing", "Xinxiang", "Shiyan", "Changsha", "Liaocheng", "Shanghai", "Wenzhou" ], "enrollment": 90, "start_date": "2026-10-19", "registry_url": "https://clinicaltrials.gov/study/NCT07847905" }, { "nct_id": "NCT07905066", "title": "Hemophagocytic Lymphohistiocytosis After Allogeneic Stem Cell Transplantation", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Hemophagocytic Lymphohistiocytosis (HLH)" ], "sites": [ "Beijing" ], "enrollment": 10000, "start_date": "2026-10-19", "registry_url": "https://clinicaltrials.gov/study/NCT07905066" }, { "nct_id": "NCT07598799", "title": "Rapid Local Ischemic Postconditioning on Stroke After Thrombectomy", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Shanghai Jiao Tong University Affiliated Sixth People's Hospital", "conditions": [ "Acute Ischemic Stroke" ], "sites": [ "Shanghai" ], "enrollment": 448, "start_date": "2026-10-18", "registry_url": "https://clinicaltrials.gov/study/NCT07598799" }, { "nct_id": "NCT07842276", "title": "Utidelone Capsules Combined With Doxorubicin for Advanced Soft Tissue Sarcoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Beijing Biostar Pharmaceuticals Co., Ltd.", "conditions": [ "Soft Tissue Sarcoma (STS)", "Utidelone", "Doxorubicin" ], "sites": [ "Chengdu" ], "enrollment": 49, "start_date": "2026-10-18", "registry_url": "https://clinicaltrials.gov/study/NCT07842276" }, { "nct_id": "NCT07849218", "title": "A Study of DXC018 in Patients With Advanced Solid Tumors", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Hangzhou DAC Biotechnology Co., Ltd.", "conditions": [ "Advanced Solid Tumors" ], "sites": [ "Fuzhou", "Jinan", "Shanghai", "Hangzhou" ], "enrollment": 110, "start_date": "2026-10-18", "registry_url": "https://clinicaltrials.gov/study/NCT07849218" }, { "nct_id": "NCT07855601", "title": "Utilization of Residual Donor Tissue for Regrafting in Bullous Keratopathy After Corneal Transplantation", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Zhongshan Ophthalmic Center, Sun Yat-sen University", "conditions": [ "Bullous Keratopathy" ], "sites": [ "Guangzhou" ], "enrollment": 20, "start_date": "2026-10-17", "registry_url": "https://clinicaltrials.gov/study/NCT07855601" }, { "nct_id": "NCT07827599", "title": "A Study to Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Hoffmann-La Roche", "conditions": [ "Influenza, Human", "Respiratory Tract Infections", "Post-exposure Prophylaxis" ], "sites": [ "Guangzhou", "Mianyang", "Changde", "Huizhou", "Ningbo", "Sanmenxia", "Shanghai", "Xiamen" ], "enrollment": 325, "start_date": "2026-10-16", "registry_url": "https://clinicaltrials.gov/study/NCT07827599" }, { "nct_id": "NCT07881458", "title": "A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Eli Lilly and Company", "conditions": [ "Obesity", "Overweight", "Diabetes Mellitus, Type 2" ], "sites": [ "Changchun", "Jinan", "Luoyang Shi", "Nanjing", "Ningbo", "Shijiazhuang", "Tianjin" ], "enrollment": 1000, "start_date": "2026-10-16", "registry_url": "https://clinicaltrials.gov/study/NCT07881458" }, { "nct_id": "NCT07748039", "title": "Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Yongjun Wang", "conditions": [ "Acute Ischemic Stroke", "Large Vessel Occlusion", "Anterior Circulation Brain Infarction" ], "sites": [ "Beijing", "Wuhan", "Xiangtan", "Rizhao", "Ya'an" ], "enrollment": 1440, "start_date": "2026-10-16", "registry_url": "https://clinicaltrials.gov/study/NCT07748039" }, { "nct_id": "NCT07882888", "title": "Iparomlimab and Tuvonralimab With With Cetuximab in Resectable OSCC", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University", "conditions": [ "Head and Neck Cancer" ], "sites": [ "Shanghai" ], "enrollment": 26, "start_date": "2026-10-16", "registry_url": "https://clinicaltrials.gov/study/NCT07882888" }, { "nct_id": "NCT07805200", "title": "Efficacy and Mechanism of Transcranial Temporal Interference Stimulation (tTIS) for Patients With Obsessive-Compulsive Disorders", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Beijing HuiLongGuan Hospital", "conditions": [ "Obsessive - Compulsive Disorder" ], "sites": [ "Hefei" ], "enrollment": 80, "start_date": "2026-10-16", "registry_url": "https://clinicaltrials.gov/study/NCT07805200" }, { "nct_id": "NCT07885397", "title": "Sonrotoclax Plus Azacitidine in Patients With MDS-IB2", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine", "conditions": [ "Myelodysplastic Syndromes, High Risk" ], "sites": [ "Shanghai" ], "enrollment": 60, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07885397" }, { "nct_id": "NCT07873645", "title": "Study of UBT37034 Injection", "status": "RECRUITING", "phase": "Phase 1", "lead_sponsor": "The United Bio-Technology (Hengqin) Co., Ltd.", "conditions": [ "Overweight , Obesity" ], "sites": [ "Changsha" ], "enrollment": 40, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07873645" }, { "nct_id": "NCT07873996", "title": "Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed Glioblastoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Beijing Tiantan Hospital", "conditions": [ "Newly Diagnosed Glioblastoma, IDH-wildtype" ], "sites": [ "Beijing" ], "enrollment": 60, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07873996" }, { "nct_id": "NCT07908888", "title": "Efficacy and Safety of Polatuzumab Vedotin, Rituximab Combined With Reduced-dose Cyclophosphamide, Doxorubicin and Prednisone Regimen in the Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma: A Multicenter, Single-arm, Prospective Study", "status": "RECRUITING", "phase": "Phase 4", "lead_sponsor": "The First Hospital of Jilin University", "conditions": [ "Diffuse Large B-Cell Lymphoma" ], "sites": [ "Changchun" ], "enrollment": 26, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07908888" }, { "nct_id": "NCT07888140", "title": "Modular Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer", "status": "RECRUITING", "phase": "Phase 3", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Esophageal Cancer" ], "sites": [ "Shanghai" ], "enrollment": 160, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07888140" }, { "nct_id": "NCT07883382", "title": "An Exploratory Study on the Use of Gecacitinib in Patients With Myeloid Malignancies and Myelofibrosis During the Peri-transplant Period Following Allogeneic Hematopoietic Stem Cell Transplantation", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Ruijin Hospital", "conditions": [ "Myeloid Neoplasms With Myelofibrosis" ], "sites": [ "Shanghai" ], "enrollment": 10, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07883382" }, { "nct_id": "NCT07854613", "title": "De Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without Omentopexy", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "China-Japan Friendship Hospital", "conditions": [ "Omentopexy", "Sleeve Gastrectomy", "Gastroesophageal Reflux Disease" ], "sites": [ "Beijing" ], "enrollment": 140, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07854613" }, { "nct_id": "NCT07884188", "title": "Becotatug Vedotin Plus Pucotenlimab for Metastatic Colorectal Cancer", "status": "RECRUITING", "phase": "Phase 2", "lead_sponsor": "Fudan University", "conditions": [ "Metastatic Colorectal Cancer" ], "sites": [ "Shanghai" ], "enrollment": 31, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07884188" }, { "nct_id": "NCT07898969", "title": "Effects of Cognitive Restructuring Intervention on Competitive State Anxiety and Volleyball Skill Performance Among Female Collegiate Volleyball Players in Guangzhou, China", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Lyu Botao", "conditions": [ "Competitive State Anxiety", "Volleyball Skill Performance" ], "sites": [ "Guangzhou" ], "enrollment": 96, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07898969" }, { "nct_id": "NCT07657169", "title": "Molecular Subtype-Guided Postoperative Radiotherapy for Phyllodes Tumor of the Breast", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": [ "Radiotherapy, Adjuvant", "Phyllodes Breast Tumor", "Prognosis", "Molecular Typing" ], "sites": [ "Guangzhou", "Shenzhen", "Jinan", "Qingdao" ], "enrollment": 160, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07657169" }, { "nct_id": "NCT07833046", "title": "Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "RenJi Hospital", "conditions": [ "Multiple Myeloma" ], "sites": [ "Shanghai" ], "enrollment": 40, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07833046" }, { "nct_id": "NCT07836660", "title": "A Study of IBI355 in Participants With Moderate-to-Severe Sj\u00f6gren's Disease", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": [ "Sj\u00f6gren's Disease" ], "sites": [ "Hefei" ], "enrollment": 198, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07836660" }, { "nct_id": "NCT07911410", "title": "Safety and Effect of Peripheral Nerve Decompression Combined With Peripheral Nerve Stimulation for Painful Diabetic Peripheral Neuropathy", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Qilu Hospital of Shandong University", "conditions": [ "Painful Diabetic Peripheral Neuropathy", "Diabetes Complication" ], "sites": [ "Jinan", "Xi\u2019an", "Hangzhou", "Chongqing" ], "enrollment": 100, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07911410" }, { "nct_id": "NCT07814664", "title": "Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus", "status": "NOT_YET_RECRUITING", "phase": "Phase 2/3", "lead_sponsor": "Chinese SLE Treatment And Research Group", "conditions": [ "Systemic Lupus Erthematosus" ], "sites": [ "Beijing" ], "enrollment": 294, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07814664" }, { "nct_id": "NCT07882056", "title": "SBRT Combined With Iparomlimab and Tuvonralimab (QL1706) and Bevacizumab for Hepatocellular Carcinoma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Peking University Cancer Hospital & Institute", "conditions": [ "Hepatocellular Carcinoma (HCC)" ], "sites": [ "Beijing" ], "enrollment": 33, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07882056" }, { "nct_id": "NCT07871526", "title": "AI-Generated and Rule-Based Individualized Feedback for Medical Students' Nephrology Learning", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Dou Fulin", "conditions": [ "Medical Education" ], "sites": [ "Jinan" ], "enrollment": 190, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07871526" }, { "nct_id": "NCT07607223", "title": "Acupuncture for Heel Pain Syndrome", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "First Teaching Hospital of Tianjin University of Traditional Chinese Medicine", "conditions": [ "Heel Pain Syndrome" ], "sites": [ "Tianjin" ], "enrollment": 150, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07607223" }, { "nct_id": "NCT07864818", "title": "Sepsis ICU Gut Microbiome Analysis", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": [ "Sepsis", "Septic Shock" ], "sites": [ "Wuhan" ], "enrollment": 180, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07864818" }, { "nct_id": "NCT07880158", "title": "Sequential Digital Intervention to Increase Influenza Vaccination in Patients With Heart Failure", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Heart Health Research Center", "conditions": [ "Heart Failure", "Influenza Vaccination" ], "sites": [ "Ruyang" ], "enrollment": 588, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07880158" }, { "nct_id": "NCT07877597", "title": "Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSS", "status": "NOT_YET_RECRUITING", "phase": "Phase 3", "lead_sponsor": "Fudan University", "conditions": [ "Locally Advanced Colon Cancer", "pMMR" ], "sites": [ "Shanghai" ], "enrollment": 480, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07877597" }, { "nct_id": "NCT07880899", "title": "The Impact of Long-term High-risk Drinking on the Effective Dose of Osselidin", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Affiliated Hospital of Jiaxing University", "conditions": [ "Sedation" ], "sites": [ "Jiaxing" ], "enrollment": 110, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07880899" }, { "nct_id": "NCT07807033", "title": "Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus Vaccine", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "CanSino Biologics Inc.", "conditions": [ "Tetanus" ], "sites": [ "Bijie" ], "enrollment": 240, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07807033" }, { "nct_id": "NCT07886476", "title": "IBI3034 Study in Healthy Adults and Patients With Primary IgA Nephropathy", "status": "NOT_YET_RECRUITING", "phase": "Phase 1", "lead_sponsor": "Innovent Biologics (Suzhou) Co. Ltd.", "conditions": [ "IgA Nephropathy (IgAN)" ], "sites": [ "Beijing" ], "enrollment": 100, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07886476" }, { "nct_id": "NCT07862972", "title": "Cryoballoon Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Shenyang Northern Hospital", "conditions": [ "Paroxysmal Atrial Fibrillation (PAF)" ], "sites": [ "Shenyang" ], "enrollment": 50, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07862972" }, { "nct_id": "NCT07830485", "title": "CM336 Plus Daratumumab and Lenalidomide in Transplant-Ineligible Newly Diagnosed Multiple Myeloma", "status": "NOT_YET_RECRUITING", "phase": "Phase 2", "lead_sponsor": "Institute of Hematology & Blood Diseases Hospital, China", "conditions": [ "Multiple Myeloma" ], "sites": [ "Tianjin" ], "enrollment": 24, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07830485" }, { "nct_id": "NCT07864844", "title": "Gut Microbiota Structure, Functional and Metabolic Profiles, and Composite Biomarkers in ICU Adults With Refractory Enteral Feeding Intolerance", "status": "NOT_YET_RECRUITING", "phase": "Observational", "lead_sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology", "conditions": [ "Refractory Enteral Feeding Intolerance", "Gut Microbiota", "Metabolic Profiles" ], "sites": [ "Wuhan" ], "enrollment": 180, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07864844" }, { "nct_id": "NCT07806058", "title": "An Open-Label, Multicenter, Phase IB/II Clinical Study of HRS-7172 in Combination With Antitumor Therapy in Participants With Solid Tumors", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Jiangsu HengRui Medicine Co., Ltd.", "conditions": [ "Pancreatic Cancer" ], "sites": [ "Shanghai" ], "enrollment": 140, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07806058" }, { "nct_id": "NCT07878351", "title": "Prospective ctDNA Testing in Large B-Cell Lymphoma", "status": "RECRUITING", "phase": "Observational", "lead_sponsor": "Peking University People's Hospital", "conditions": [ "Diffuse Large B Cell Lymphoma (DLBCL)", "High Grade B Cell Lymphoma" ], "sites": [ "Beijing" ], "enrollment": 100, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07878351" }, { "nct_id": "NCT07903467", "title": "Generative AI-Assisted Personalized Feedback for Laparoscopic Skill Learning in Medical Undergraduates", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Yang Xiaodong", "conditions": [ "Medical Education" ], "sites": [ "Jinan" ], "enrollment": 40, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07903467" }, { "nct_id": "NCT07596134", "title": "Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Zhejiang University", "conditions": [ "Unresectable Hepatocellular Carcinoma (HCC)" ], "sites": [ "Kaifeng", "Nanchang", "Aksu", "Hangzhou", "Jiaxing", "Taizhou" ], "enrollment": 166, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07596134" }, { "nct_id": "NCT07895082", "title": "Quanduzhong Capsules for Primary Osteoporosis", "status": "ENROLLING_BY_INVITATION", "phase": "Phase 3", "lead_sponsor": "Shanghai University of Traditional Chinese Medicine", "conditions": [ "Primary Osteoporosis" ], "sites": [ "Shanghai" ], "enrollment": 300, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07895082" }, { "nct_id": "NCT07882641", "title": "BEX101 in B-cell Non-Hodgkin's Lymphoma", "status": "RECRUITING", "phase": "Phase 1/2", "lead_sponsor": "Chinese PLA General Hospital", "conditions": [ "Non-Hodgkin's Lymphoma" ], "sites": [ "Beijing" ], "enrollment": 20, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07882641" }, { "nct_id": "NCT07854626", "title": "Venipuncture Via Nurse-AI Collaboration", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University", "conditions": [ "Peripheral Venous Cannulation for Contrast-enhanced CT/MRI Examination", "Peripheral Venous Access Establishment" ], "sites": [ "Guangzhou" ], "enrollment": 3500, "start_date": "2026-10-15", "registry_url": "https://clinicaltrials.gov/study/NCT07854626" }, { "nct_id": "NCT07806045", "title": "Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement", "status": "NOT_YET_RECRUITING", "phase": "Early Phase 1", "lead_sponsor": "Qiubai Li", "conditions": [ "IgG4 Related Disease", "Systemic Sclerosis (SSc)" ], "sites": [ "Beijing" ], "enrollment": 18, "start_date": "2026-10-14", "registry_url": "https://clinicaltrials.gov/study/NCT07806045" }, { "nct_id": "NCT07638761", "title": "Efficacy Evaluation of Intelligent Rehabilitation Programs Based on AI-Powered Digital Rehabilitation System for Subacromial Impingement Syndrome", "status": "NOT_YET_RECRUITING", "phase": "Not applicable", "lead_sponsor": "Peking University Third Hospital", "conditions": [ "Articular", "Range of Motion" ], "sites": [ "Beijing" ], "enrollment": 93, "start_date": "2026-10-14", "registry_url": "https://clinicaltrials.gov/study/NCT07638761" }, { "nct_id": "NCT07845682", "title": "A Study of Dual Energy THERMOCOOL SMARTTOUCH\u2122 SF Catheter With TRUPULSE\u2122 Generator in Persistent Atrial Fibrillation", "status": "RECRUITING", "phase": "Not applicable", "lead_sponsor": "Biosense Webster, Inc.", "conditions": [ "Atrial Fibrillation" ], "sites": [ "Beijing", "Jinan", "Nanjing", "Shanghai" ], "enrollment": 150, "start_date": "2026-10-14", "registry_url": "https://clinicaltrials.gov/study/NCT07845682" } ] }